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The overdose crisis has been an issue of public health and safety in the U.S. over  
the past 30 years, as a wave of increased addiction and overdoses beginning in 1990 
brought it to public attention and political salience.1 The impact of the current overdose 
crisis is felt deeply across the state of Connecticut and locally in the City of New Haven. 
Statewide data show that people in Connecticut are more likely to die from a drug 
overdose than they are from a car accident, firearm death or homicide, Alzheimer’s, 
influenza/pneumonia, diabetes, kidney disease, or septicemia (data not including deaths 
due to the COVID-19 virus).2,3 Within the state, New Haven County accounted for 25% 
of all drug overdose deaths from 2015-2020 and the City of New Haven itself has the 
second most drug overdose deaths in the county, placing it among the top five cities in 
the state for drug overdose deaths.4  
This thesis compiles information from global examples of successful 
implementation of supervised consumption facilities (SCFs), as well as national 
examples of current efforts for implementation, and explores the evidence regarding the 
ability of SCFs to alleviate some impacts of the overdose crisis. The information from 
this compilation is then paired with insights from a qualitative study of key informant 
interviews in New Haven, Connecticut.  I conducted this qualitative analysis to focus on 
the facilitators and barriers to SCF implementation in New Haven, Connecticut; 
moreover, I  use John Kingdon’s “Multiple Stream Theory”5 in order to distill evidence 
regarding the potential for changing the policies and/or practices needed to establish 
SCFs. After review of all evidence, it appears that New Haven is considering policy 
changes which would support  SCF implementation. However, the work of SCF 
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implementation in New Haven will need to include more than just policy change. The 
process of SCF implementation will require relationship building and trust development 
among various communities in New Haven (e.g., residents of New Haven 
neighborhoods, business owners, religious communities, physicians, service providers, 
etc.) in order to work towards various forms of buy-in from these communities, ranging 
from active support to non-interference. Lastly, and crucially, this work needs to 
meaningfully include and center the voices of people who use drugs (PWUDs) in every 
step of the process. PWUDs need to be involved in all policy change and program 
implementation that concerns their health and well-being. Those in New Haven looking 
to implement SCFs need to listen to those with lived experience, incorporate their 




Table of Contents 
I. LIST OF TABLES ................................................................................................................................................. 6 
II. INTRODUCTION AND BACKGROUND ON THE OVERDOSE CRISIS: NATION, STATE, 
AND CITY ................................................................................................................................................................... 7 
III. THE EVIDENCE SUPPORTING SUPERVISED CONSUMPTION FACILITIES: A BRIEF 
SUMMARY .............................................................................................................................................................. 12 
IV. CONTEXTUALIZED SNAPSHOTS OF SUPERVISED CONSUMPTION FACILITIES ......... 14 
A. THE NETHERLANDS....................................................................................................................................... 15 
B. SWITZERLAND................................................................................................................................................ 17 
C. CANADA ......................................................................................................................................................... 19 
V. INITIAL EFFORT TO OPEN SCFS IN THE U.S.................................................................................... 25 
A. SAN FRANCISCO, CALIFORNIA ....................................................................................................................... 26 
B. NEW YORK STATE AND ITHACA, NY ............................................................................................................. 28 
C. PHILADELPHIA, PENNSYLVANIA ................................................................................................................... 30 
VI. FEDERAL LAW: A KEY BARRIERS TO SCFS IN THE U.S. .......................................................... 32 
VII. A QUALITATIVE STUDY OF THE POTENTIAL FOR SCF IMPLEMENTATION IN NEW 
HAVEN, CT .............................................................................................................................................................. 34 
A. CONCEPTUAL FRAMEWORK ........................................................................................................................... 35 
B. METHODS: QUALITATIVE STUDY WITH LOCAL KEY INFORMANTS ................................................................ 36 
C. FINDINGS AND ANALYSIS: UNDERSTANDING BARRIERS AND ACKNOWLEDGING OPPORTUNITY................ 37 
C1. Barriers....................................................................................................................................................... 37 
C2. Facilitators ................................................................................................................................................ 46 
C3. Next Steps .................................................................................................................................................. 51 
C4. The Sine Qua Non of Meaningful Policy Change: Policy option, Political circumstances, and 
Problematization ............................................................................................................................................. 52 
C5. Keep in Mind: Contextualizing Kingdon’s Theory in New Haven’s Reality ................................... 57 
D. DISCUSSION AND STRATEGIC PLANNING ...................................................................................................... 61 
D1. Applying Kingdon’s Theory of ‘Alignment’ to New Haven ................................................................ 62 
D2. Working Towards Aligned Problematization ..................................................................................... 64 
D3. Additional Strategic Planning ............................................................................................................... 65 
E. LIMITATIONS OF THIS STUDY ........................................................................................................................ 72 
VIII. CONCLUSION.............................................................................................................................................. 73 
IX. CITATIONS ...................................................................................................................................................... 75 
X. APPENDICES .................................................................................................................................................... 81 
A. APPENDIX A: RECRUITMENT EMAIL ............................................................................................................. 81 
B. APPENDIX B: QUALITATIVE INTERVIEW GUIDE ........................................................................................... 82 




I. List of Tables 
 
Table 1. Impact of Insite Across Personal Outcomes  
 
Table 2. Impact of Insite Across Community Outcomes 









II. Introduction and Background on the Overdose Crisis: Nation, 
State, and City 
 
This thesis seeks to provide an understanding of the barriers and facilitators to 
implementation of supervised consumption facilities (SCFs) in New Haven, as well as 
determine the current climate of opinions, understanding, and will for sanctioned 
implementation. In order to do so, I first provide background on the overdose crisis, it’s 
morbidity and mortality, and the trends that are currently seen across the country, the 
state of Connecticut, and locally in New Haven. From there, I highlight the evidence in 
support of supervised consumption as a harm reduction intervention, inclusive of 
personal, community, and economic impacts. While the evidence in support of 
supervised consumption is highly compelling, it alone is not enough to understand the 
complexities that come with the process of implementation. In order to understand this 
complexity, I explore how SCFs have been previously implemented using three global 
examples of supervised consumption operationalization, the factors that contributed to 
implementation, and key takeaways that provide lessons for SCF implementation in 
New Haven. In addition to these global contexts, I draw on the lessons from three 
different examples of efforts to implement supervised consumption in the U.S., as well 
as the barriers to implementation present in federal law, in order to provide more 
information on the national context in which New Haven is situated. Finally, this thesis 
explores the potential for SCF implementation at a local level in New Haven through a 
qualitative study of key informant interviews analyzed through the lens of context and 
interest convergence, taking into account key actors, policies, positionalities, and public 
opinion. The themes and analysis highlighted in this qualitative study make visible the 
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need and opportunity for supervised consumption in New Haven, as well as provide 
nuance to how one may go about SCF implementation.  
 
The current public health emergency commonly referred to as the opioid crisis 
has become a particularly salient public health and safety topic in the U.S. in the past 30 
years, since the current wave of increased addiction and overdoses began in 1990.1 
Although the roots of more widespread opioid use, opioid use disorder, and oppressive 
involvement of the U.S. government in regulating opioids dates back centuries,6 the 
causes of the current crisis are multifaceted. The 1990s saw an increase in opioid 
prescribing for pain management, fueled by the real concern of undertreated pain, but 
blown out of proportion due to a confluence of deceptive marketing and abusive 
practices of drug companies (in which drug companies, such as Purdue Pharma, made 
false claims about abuse potential of their extended-release opioid formulations, 
provided incentives to promote sales, and obtained endorsements from leading 
physicians), a shift towards patient centered medical care (in order to reduce the 
suffering associated with surgery and/or trauma recovery, chronic pain, or terminal 
illness, which required self-reported pain assessment without objective reference 
points), and a decrease in the amount of time physicians spent with their patients (due 
to enforced time constraints on physician-patient interactions, making the prescription 
of opioids quicker and easier than working through behavioral approaches to pain 
management).6 The recognition of this untoward increase in opioid prescriptions led 
policymakers to enforce a short-sighted, reactionary shift in supply-side practices, 
restricting the amount of prescription opioids available without addressing the 
demand.6 This now unmet need for pain management, in turn, is linked to the 
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emergence of a market for diverted pharmaceuticals and ultimately, an increased 
market for narco-trafficking of heroin and fentanyl.a,6 The increased availability of 
heroin and fentanyl meant that opioid use transitioned toward an increase in the use of 
injection heroin and fentanyl, which correlates with an increase in infections, addiction 
and overdoses. Now we find ourselves in the midst of the overdose crisis, with deaths 
from synthetic opioid overdoses on the rise since 2013.8,9 Now, in 2021, the United 
States is still struggling to effectively curb the morbidity and mortality associated with 
addiction and overdoses. In 2018, nearly 70% of drug overdose deaths involved an 
opioid, and the number of deaths due to overdose was four times higher than in 1999.10 
Although the morbidity and mortality, associated with opioid use in the U.S. is 
staggering, it is important to understand that it is only one piece of the broader overdose 
crisis, collectively creating additional morbidities and impacts, including but not limited 
to increases in infectious disease,11 mass incarceration as a result of the War on Drugs 
leading to familial disruption (particularly in communities of color),12,13 loss of voting 
rights related to drug felonies,14,15 and male depopulation of policed communities 
(particularly communities of color).12,13,16 Additionally, the overdose crisis has claimed 
over half a million lives since 2000.17 Recent decades have also seen an increase in 
overdose morbidity and mortality related to the use of stimulant drugs, namely 
methamphetamine and cocaine. Overdose mortality involving cocaine and 
methamphetamine has risen steeply starting in 2009, with a ten-fold increase by 2019, 
and marked by 16,196 and over 16,500 overdose deaths respectively.18 
 
a Pharmaceutical fentanyl is a synthetic opioid that has been approved for the treatment of severe pain. It is 50 to 100 
time more potent than morphine. However, much of the fentanyl that is resulting in increased overdose deaths and 
drug-related harm among PWUDs in the U.S. is illegally manufactured and is often mixed with and sold in other 
drugs, such as heroin or cocaine, with our without the purchaser’s knowledge.7 
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However, while stimulant-related overdose has steeply increased, stimulant use 
has not experienced the same trend, with reported stimulant use fluctuating from year 
to year.18 This indicates that the increase in stimulant-related overdoses is likely due to 
individuals intentionally using stimulants in combination with opioids, like heroin or 
fentanyl, or using stimulants that have been cut with opioids without their knowledge 
due to a tainting of the drug supply.18 Additionally, the COVID-19 pandemic has only 
exacerbated the overdose crisis nationwide. According to the CDC, a record number of 
drug overdose deaths, 81,000, occurred from June 2019 to May 2020: deaths related to 
synthetic opioid use were up 38%, deaths related to cocaine use were up 27%, and 
methamphetamine overdoses increased by 35%.19 Officials suggest that this is likely due 
to the impact of COVID-19,19 in which many people were most likely using drugs alone, 
with no one there to assist them in the case of an overdose. This evidence points to the 
clear conclusion that the overdose crisis is only getting worst, despite any efforts to 
alleviate its impact, and more needs to be done.  
The national trends in the use of and overdoses related to opioids and other drugs 
hold true for Connecticut as well. The state is no stranger to the deleterious impacts of 
the overdose crisis. In relation to other states, data from 2018 put the opioid related 
deaths in Connecticut at 27.5 per 100,000, placing the state as the 6th highest in the 
country for opioid related overdose deaths.20 Additional 2018 data show that the age-
adjusted drug overdose rate in Connecticut was 30.7 per 100,000 population, placing it 
as the 11th highest state in the nation for drug overdose deaths.10 Recent national data 
show that opioid related overdose deaths declined in 2018 but began increasing again in 
2019 and rose to record levels in 2020.21–23 The decline of opioid related overdose 
deaths in 2018 was, “largely explained by reductions in deaths from prescription opioid 
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medications” and those declines have been reversed by the increasing overdose related 
deaths due to illicit drug use.21 According to the Connecticut Department of Public 
Health (DPH), residents of the state are more likely to die from an unintentional drug 
overdose than from a car accident.2 Additionally, according to CDC data, the overdose 
death rate in Connecticut greatly surpassed other causes of death, such as firearm death 
and homicide, at 4.9 and 2.8 per 100,000 respectively.3 These age-adjusted rates place 
drug overdose among the top 10 leading causes of death in Connecticut above 
Alzheimer’s, influenza/pneumonia, diabetes, kidney disease, and septicemia.3 Although 
there have been nearly 8,000 deaths in Connecticut due to COVID-19,24 data on the 
leading causes of death in the state do not currently reflect the death rates of COVID-19 
compared to overdoses. Additionally, as with national trends, it would be ill-advised to 
ignore the role that COVID-19 played in the record number of overdoses in Connecticut 
in 2020. Through October 2020, Connecticut saw a 13% increase in drug overdoses 
compared to the previous year,25 again potentially associated with the impact that 
COVID-19 had on people using drugs alone and without anyone to assist them in the 
case of an overdose.  
In Connecticut, the decline in opioid related drug overdoses in 2018, with 
overdose deaths associated with heroin decreasing in 2018 while overdose deaths 
related to fentanyl increased, is a reflection of the shifting illicit opioid market: fentanyl 
has replaced heroin in the state.4 Statewide data from the Connecticut DPH shows that 
2020 had the highest number of drug overdose deaths since 2015, with fentanyl and 
heroin overdoses contributing the most to mortality, followed closely by cocaine.26 The 
data available from the Office of the Chief Medical Examiner also break down the drug 
overdose data by city and county. Since 2015, there have been 1,555 drug overdose 
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deaths in New Haven County, accounting for approximately 25% of all drug overdose 
deaths in the state of Connecticut from 2015-2020.4 Additionally, there have been 273 
drug overdose deaths in the city of New Haven since 2015, making it second only to 
Waterbury for most overdose deaths in the county and among the top five cities in the 
state for drug overdose deaths.4 Additionally, the substances associated with overdose 
deaths in both New Haven County and the City of New Haven match statewide trends, 
with fentanyl, heroin, and cocaine contributing the most to mortality.4 
III. The Evidence Supporting Supervised Consumption Facilities: 
a brief summary  
 
The statistics on drugs overdoses indicate that the public health threats 
associated with overdose are present and pressing in the state of Connecticut. While 
certain harm reduction methods and treatments, such as syringe exchanges, outreach 
services that provide harm reduction materials, and medication assisted therapy have 
been implemented for people who use drugs (PWUDs) and people with substance use 
disorders, these methods were designed for ameliorating certain side-effects of injection 
drug use, or drug use itself, but are not designed to protect against drug overdoses and 
their consequences, including death. As noted by Beletsky et al, “These interventions do 
not address the lack of a safe and hygienic setting for injection, nor are they sufficient to 
overcome the behavioral influence of relationships and other factors present in informal 
injecting milieus,”27 that can lead to overdose. As one of the top five cities in the state in 
overdose deaths, New Haven is not currently meeting the needs of PWUDs in order to 
reduce drug related overdose death. It stands to reason that if current interventions are 
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not and cannot be successful in this mission, it may be time to explore other options that 
have proven efficacious elsewhere.  
Supervised consumption facilities (SCFs), also known as overdose prevention or 
risk management sites, show promise in ameliorating some of the health and human 
costs of the overdose crises. At time of writing, they have yet to be officially or formally 
implemented in Connecticut or in the United States. As defined by the Drug Policy 
Alliance, SCFs, “allow people to consume pre-obtained drugs under the supervision of 
trained staff and are designed to reduce the health and public order problems often 
associated with public drug consumption.”28 Additionally, SCFs can serve to reduce the 
some of the dangers of private drug consumption, such as using alone, without someone 
there to witness and respond to an overdose event. With regard to reducing the 
morbidity and mortality associated with drug use and drug overdoses, a review of 
evidence on SCFs operating outside the U.S.  shows that they have been associated with 
a reduction in deaths from overdose, an increase in injection cessation, and a reduction 
in infections including HIV, hepatitis C virus, and soft tissue infections.29–32 Additional 
evidence supports that SCFs are particularly  efficacious in preventing fatal overdoses, 
with zero fatal overdoses being reported within supervised facilities.33,34  
In addition to the evidence supporting supervised consumption for the impact 
this intervention has on individual outcomes for PWUDs, SCFs also have a marked 
impact on the community around the facility. Supervised facilities have been linked to a 
decrease in overdose related deaths in the area around a site, not just among those who 
access the site.35 Additionally, SCFs lead to a decrease in what are commonly referred to 
as “public nuisance occurrences,” including public injection or drug use, public 
discarding of materials used for drug use, and public intoxication while also being 
 14 
shown to increase access to health and other social services.36,37 SCFs have been shown 
to decrease drug related crime and violence in the neighborhoods around the site as well 
as decrease the demand for ambulance services for opioid-related overdoses.38,39 While 
the evidence strongly supports the efficacy of SCFs as harm reduction spaces for 
PWUDs, there is also promising evidence regarding support for these sites from the 
general public. It has been shown that once implemented, the support for a SCF 
increases over time.17,40–42 A final consideration that often comes up when 
discussing  SCFs is the evidence around the associated financial savings. It has been 
estimated that the implementation of a SCF in a U.S. city would save approximately $3.5 
million a year, when considering savings in avoided HIV and HCV infections, reduced 
skin and soft tissue infection, avoided deaths, and an increased uptake in medication 
assisted treatment.43 When taking into account cost savings for the healthcare system, 
including a decrease in ambulance rides, emergency department visits, and hospital 
stays associated with drug use and overdose, the savings range from $3.6 - $4.2 million 
in American cities.44  
IV. Contextualized Snapshots of Supervised Consumption 
Facilities 
 
While the practice of informally supervising others during their drug use as a 
harm reduction strategy distinctly predates the implementation of any legislatively 
sanctioned or governmentally condoned SCFs, the analyses presented here will review 
notable achievements among sanctioned SCFs or unsanctioned SCFs that subsequently 
became sanctioned. Although not all are analyzed here, currently, there are about 120 
sanctioned SCFs operating in ten different countries—all outside the U.S.28 – indicating 
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that this intervention is tested, proven to work, and is a widely accepted way to move 
forward on harm reduction. Sanctioned supervised consumption services are currently 
available to PWUDs in Australia, Canada, Denmark, Luxembourg, The Netherlands, 
Norway, Spain, France, Germany, and Switzerland.28 Although SCFs are generally 
thought of as sites that are exclusively used by people who inject drugs, often referred to 
as supervised injection facilities (SIFs) – a specific type of SCF -- many do allow for 
other methods of drug consumption, and therefore it is important to use the phrase 
“people who use drugs,” or PWUDs, rather than the more restrictive, “people who inject 
drugs,” or PWIDs. However, if specific context of a particular location’s history 
indicated that SCF implementation was born out of addressing the needs of PWIDs, this 
acronym, as was as the SIF acronym, will be used for accuracy to the history/site 
analysis. Everywhere else, PWUD will be used.  
This section provides examples of SCF implementation around the world that 
inform the potential avenues of and considerations for SCF implementation in the U.S. 
and, more specific to this work, in New Haven, CT. These global examples provide 
insight into how SCFs/SIFs were able to open in other countries and the factors that 
were vital to their success. Reviewing this history serves to determine what factors and 
how these factors can be applied or incorporated into the efforts to implement SCFs in 
New Haven, CT. 
 
A. The Netherlands 
Most histories of supervised consumption begin with the first unsanctioned 
supervised consumption facility being opened in the Netherlands in the 1970s.45,46 In 
the time preceding its opening, there was a cultural shift in how the Dutch people 
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viewed drug use, particularly among youth.45 “‘Deviant behavior,’ including drug use, 
was no longer seen as a maladjustment, but as a part of testing the limits while defining 
a personal way of life.”45 The movement for SCFs in the Netherlands derived from the 
organizing of young people who did not want to stop their drug use or could not stop 
their drug use because the traditional forms of drug services did little for them.45 Youth 
mobilization was supported by the church and an unsanctioned supervised consumption 
facility was opened near Rotterdam Central Station by a reverend of St. Paul’s Church to 
provide an alternative to street-based drug use.45 This site also experienced unofficial 
support from some law enforcement and local government.45 A second site opened 
within St. Paul’s Church itself and expanded after the closing of the first site.45 Each of 
these sites included multiple facets of harm reduction including basic medical care, 
counseling, food, laundry, showers, and drug consumption facilities.45 
It took nearly two decades for there to be any movement from the government 
regarding supervised consumption in the Netherlands. In 1996, the City of Rotterdam 
officially supported the St. Paul’s Church SCF.45 The 1990s also brought about a shift in 
thinking about policing, noting that “constraint and pressure alone” were not a 
sufficient response to drug use.45 In October of 1996, in a key turning point for SCF 
implementation, the establishment of official SCFs became feasible after the College van 
Procureurs-general, the Board within The Hague that determines investigation and 
prosecution policy for The Netherlands,47 issued legal guidelines clarifying that 
possession of drugs in these consumption rooms was to be tolerated as long as the 
facilities fit into the local drug policy framework.46 Supervised consumption facilities 
were then elevated and supported by city councils, the police, the Public Prosecutor, and 
the national government.45 
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At present, Dutch SCFs are operated by municipalities and offer services 
including basic harm reduction and recreational use activities, health education, nursing 
services, infectious disease testing and referral to treatment, additional treatment 
referrals, and daytime activities.48 Many SCFs in The Netherlands now provide 
supervised smoking and supervised snorting rooms along with supervised injecting 
rooms.48 While some of these services may seem radical when thinking about the 
discussions of harm reduction currently taking place in the United States, they lend 
themselves to the idea that there is more that can be done to provide safer services, 
supply, and spaces for PWUDs.  
The example from The Netherlands shows a distinct progression from an 
unsanctioned SCF opened out of need to sanctioned SCF supported by the government, 
law enforcement, and citizens. It is notable that unsanctioned SCFs in The Netherlands 
were able to operate as the result of non-interference and unofficial support from local 
governments and law enforcement before progressing to legal operation after policy 
change. This represents one viable pathway to SCF implementation.  
 
B. Switzerland  
 The first SCF in Switzerland was opened in 1986.45 In the 1980s, health workers 
began to notice that PWID were injecting publicly after being kicked out of cafes and 
restaurants.45 These health workers then set up separate cafes specifically for use by 
PWID who began injecting on-site while the health workers could monitor them and 
help to modify riskier behaviors.45 In July 1998, a working group comprised of judges 
and the General Prosecutor completed a legal assessment regarding SCFs, a key move in 
the effort for SCF implementation.46 This assessment, commissioned by the Swiss 
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Federal Office for Public Health, concluded that, “the establishment of state-controlled 
consumption rooms does not violate Swiss national drugs legislation as long as the 
rooms improve the hygienic conditions under which consumption takes place and 
provide medical supervision and no drug dealing takes place.”46 As a result of this 
assessment, Swiss SCFs were deemed to be medical institutions and were therefore 
exempt from any police intervention.46  
The Swiss model of consumption rooms tends towards a small, discrete room 
within a cafe that includes several stainless steel tabletops where clients can sit to 
prepare their drugs for injection.45 In these rooms, PWID are provided with the full 
range harm reduction materials needed by people who inject drugs including needles, 
syringes, candles, sterile water, spoons, paper towels, cotton pads, bandages, and 
garbage bins.45 Although staff are not allowed to assist in injection, patrons of the cafe 
are permitted to assist one another.45 Cafes additionally include counselling rooms, 
medical clinics for primary care, referral to drug treatment for those who request it, free 
soup, tea and coffee, and cheap fruit and vegetables.45 The sterility of the supervised 
consumption rooms in the Swiss models is reflected to this day in the sterile, 
medicalized formats that are very common among SCFs.  
The history of SIFs in Switzerland is marked by a different progression than that 
of The Netherlands. Although SCF implementation in Switzerland also began with 
unsanctioned sites opened out of need, SCFs were able to move into legality through a 
new interpretation of a law that was already in place. This interpretation allowed for 
SIFs to be considered medical facilities, which was key to their legal operation. Given 
the current status of federal drug law in the United States, the pathway to SCF 




 When discussing SCFs, especially in the context of the potential for their 
deployment in the United States, one example that frequently comes up is Insite, the 
first SCF in North America, which opened in the fall of 2003 in Vancouver, following 
approval from Health Canada in June of that year.49 Insite was a triumph for the PWID 
community after a long and hard-fought political advocacy campaign.  
Prior to the opening of Insite, the mid-late 1990s saw a peak in drug related 
harms in Vancouver.50 Annual HIV infection rates were sitting around 19% for PWIDs in 
Vancouver and there were over 300 overdose deaths in British Columbia, resulting in 
the declaration of a public health emergency by Vancouver’s health authority.51 In 1994, 
in a key origin moment for SCF implementation in Canada, a group organized under the 
Provincial Chief Coroner of British Columbia published the “Cain Report,”52 which 
included recommendations for Vancouver to explore the implementation of supervised 
injection facilities based upon the evidence from facilities in Europe.51,53 When there was 
very little governmental movement after the Cain Report was published, local activists 
and PWID took matters into their own hands, opening an unsanctioned SIF in 1995.51 
Although this site was closed by police about one year after its opening, the push for a 
SCF in Vancouver never stopped.51 In 2000-2001, the City of Vancouver released its 
Four Pillar Drug Strategy, which explicitly called for the opening of two SIFs in the 
city.51 Although a lack of authority to implement health programs prevented immediate 
action (due to provinces controlling the responsibility for healthcare administration, not 
cities), the announcement of the Four Pillar Drug Strategy was followed by a sequence of 
events that catalyzed the movement for supervised injection, including visits from 
European officials with SIF experience, the drafting of a full proposal for a pilot SIF by 
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the Harm Reduction Action Society, the mayoral election of Larry Campbell in 2002 
who promised to establish a SIF within a month of being elected, the opening of another 
unsanctioned SIF after a police crackdown in Vancouver’s Downtown Eastside, and the 
practice of supervising injections by nurses at the Dr. Peter Centre, a residence for 
people living with HIV.51 When it opened in September of 2003 as North America’s first 
legally sanctioned SIF, Insite operated as a three year long scientific pilot program and 
was therefore exempt under Section 56 of the Canadian Controlled Drugs and 
Substances Act, a key factor in its success.46,51 Since its opening, Insite has been 
rigorously studied and evaluated, with publications attesting to the site’s impact, 
including a reduction in overdose deaths in and around the facility,34,35 reduction in 
mortality associated with injection-related skin infections,54 injection cessation,55 an 
increase in rates of addiction treatment uptake, both detoxification and long term 
treatment,56,57 a reduction in syringe sharing,49 reduction in public drug use and public 
disposal of drug paraphernalia,37 no increase in crime, including drug trafficking, 
assaults, or robbery and a decrease in vehicle break-ins and theft,39 an increase in 
uptake of services from higher risk individuals, including people who are homeless, 
people who inject cocaine, people who need assistance injecting, and sex workers,58,59 
and savings in cost and strain on the city, government, and health care system.60,61 
Tables 1, 2, and 3 show the impact Insite made on personal outcomes, community 
outcomes, and savings, along with the duration of the studies. Impacts are noted here in 





Table 1. Impact of Insite Across Personal Outcomes 
Outcome Impact Study Duration Citation 
# 
Overdose death averted 
within Insite 
1.9-11.7 deaths/year 03/01/04 –07/01/08 34 
Overdose death around 
Insite 
35% decrease in fatal 
overdose within 500 
meters of Insite (compared 
to 9.3% elsewhere in 
Vancouver) 
01/01/01 - 09/20/03 
compared to 





Remained under 10% 01/04/04 – 12/31/05 54 
Injection cessation 
Cumulative incidence of 
23.06% 
12/01/03 – 06/01/06 55 
Addiction treatment 
uptake (detoxification) 
Increase in use of 
detoxification (Odds ratio 
1.32) 
12/01/03 – 03/01/05 56 
Addiction treatment 
uptake (detoxification) 
Increase in rapid entry into 
detoxification (Odds ratio 
1.72) 
12/01/03 – 03/01/05 57 
Long term addiction 
treatment uptake (after 
detoxification) 
Elevated rates of 
methadone initiation 
(Relative hazard 1.56) and 
other addiction treatment 
(Relative hazard 3.73) 
12/01/03 – 03/01/05 56 
Service uptake of Insite 
43.2% reported using the 
SIF daily 
12/01/03 – 07/30/04 59 
Syringe sharing 
Reduced syringe sharing 
(adjusted odd ratio 0.30) 
12/01/03 – 06/01/04 49 
Increase in Safer 
Injection Education 
Among those who need 
help injecting (Odds ratio 
2.20); Among sex-workers 
(Odds ratio 1.54) 








Table 2. Impact of Insite Across Community Outcomes 
Outcome Impact Study Duration Citation 
# 
Syringe sharing 
Reduced syringe sharing 
(adjusted odd ratio 0.30) 
12/01/03 – 06/01/04 49 
Public drug use 
Predicted daily mean 
reduction from 4.3 to 2.4 
people injecting in public 
08/11/03 – 09/21/03 
compared to 




Predicted daily mean 
reduction from 11.5 to 5.4 
publicly discarded syringes 
08/11/03 – 09/21/03 
compared to 
09/22/03 – 12/15/03 
37 
Drug trafficking 
No change in crude totals 
(124 vs. 116) 
10/01/03 – 09/30/04 
compared to 
10/01/04 – 09/30/05 
39 
Assaults/Robbery 
No change in crude totals 
(174 vs. 180) 
10/01/03 – 09/30/04 
compared to 
10/01/04 – 09/30/05 
39 
Vehicle break-in/theft Decrease (302 vs. 227) 
10/01/03 – 09/30/04 
compared to 
10/01/04 – 09/30/05 
39 
 
Table 3. Impact of Insite On Cost Savings 
Factors Considered Impact Study Duration Citation 
# 
Accounting for prevention 
of death and new cases of 
HIV 
$6 million/year 
Data from various 
years of Insite’s 
operation and sources 
of cost estimations 
61 
Accounting for decreased 
syringe sharing 
$14 million saved and 920 
life-years gained over 10 
years 
10-year time horizon 
from study conducted 
in 2008 
60 
Accounting for decreased 
syringe sharing and 
increased safe injection 
practices 
 
$20 million saved and 
1,070 life-years gained over 
10 years 
10-year time horizon 
from study conducted 
in 2008 
60 
Accounting for decreased 
syringe sharing, increased 
safe injection practices, and 
referrals to methadone 
maintenance treatment 
$18 million saved and 1,175 
life-years gained over 10 
years 
10-year time horizon 





In 2006, the last year of the pilot program, Canada’s national election resulted in 
seating a Conservative government that was publicly opposed to harm reduction. The 
years following the election were fraught with legal battles that pitted the federal 
government against British Columbia and Insite over whether or not the facility would 
remain open.51 Three rulings, first by the Supreme Court of Canada, then an appellate 
court, and finally a second hearing by the Supreme court of Canada, resulted in 
judgements in favor of Insite. This is a highly impactful decision, with a court judgement 
ruling in favor of an evidence-based practice. In 2011, the rulings required that the 
federal government revise its policies to allow for the legal operation of SIFs in 
Canada.51,62 The federal government responded to this with Bill C-2, a highly 
prescriptive and restrictive list of twenty-six conditions that needed to be met before a 
supervised consumption facility could be opened.51 The political landscape in Canada 
shifted once again in 2015 with the election of a Liberal government under Justin 
Trudeau as Prime Minister, whose government came out openly in support of 
supervised consumption.51 As overdoses once again began to rise across Canada, the 
new Liberal government replaced Bill C-2 with Bill C-37, reducing the twenty-six 
conditions to open a supervised site down to five.51 
The 2011 Supreme Court of Canada decision and the replacement of Bill C-2 with 
Bill C-37 very clearly had ramifications for harm reduction and SCF implementation 
across Canada. The reduced number of conditions in combination with the Canadian 
government’s commitment to facilitating a timely review and implementation of 
proposals for supervised facilities meant that Health Canada was able to announce the 
approval of several new facilities across the country, including Toronto, Montreal, 
Edmonton, Vancouver, Surrey, and Victoria,63 with sites also considered in Ottawa.51 In 
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order to expand to meet the needs of PWUDs across Canada, it was crucial that each of 
these cities conduct their own analyses with regard to what model of supervised 
consumption would work in their municipality and for their populations. It would have 
been ill-advised to simply copy and paste Insite’s model into another city without 
considering the needs, circumstances, and conditions of PWUDs in the local context. 
Cost-effectiveness studies in both Toronto and Montreal indicated that although a single 
site was able to reach a large population of PWUDs in Vancouver, multiple smaller sites 
throughout these cities would be more efficacious.64–66 Similarly, in addition to their 
fixed sites, Montreal implemented a mobile site in order to better reach populations of 
PWUDs who are more dispersed throughout the city.67,68  
The process of SCF implementation is Canada was notably fraught. The move 
towards supervised consumption was set in motion by the Cain Report, initiated within 
the government. Despite the findings of this report, indicating the recommendation that 
SCFs be explored in Vancouver, it was a lack of action that ultimately spurred the 
opening of unsanctioned sites. The role of the government and the courts was highly 
influential in the case of SCFs in Canada, with differing court rulings and shifts in which 
political ideologies were in power greatly contributing to how supervised consumption 
was able to progress. The influence of the government and the courts could prove to be 
highly influential in the case of SCF implementation in New Haven as well, making the 
Canadian history of supervised consumption an important example. Additionally, the 
expansion of supervised consumption across Canada contains important lessons for 
application in New Haven. An assessment of what model, or combination of models, 
would be most effective and acceptable to the population of PWUDs in New Haven will 
be an important feature of potential SCF implementation. 
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V. Initial Effort to Open SCFs in the U.S. 
 The implementation of supervised consumption facilities globally has 
demonstrably influenced the discussion around implementation in the United States. 
While U.S.-based, harm reduction oriented PWUDs, service providers, and physicians 
have been pushing for SCFs as a life-saving and evidence-based intervention for 
decades, the country has yet to see the opening of any sanctioned SCFs. As before, it is 
highly important to note that these efforts happen regardless of sanction. There are 
unsanctioned SCFs operated by service providers and peers across the country. Their 
lack of legal or administrative sanction does not take away from the lives they’re saving, 
the improvements in health and well-being they are facilitating, and the groundwork 
they are laying. In addition to this work, several cities in the U.S. are working towards 
the implementation of sanctioned SCFs. As with the global examples of SCF 
implementation, there are many cities and organizations across the U.S. that have been 
working towards the implementation of a supervised site. This section outlines the 
efforts in three cities – San Francisco, Ithaca, and Philadelphia – as examples, but these 
are by no means an exhaustive account of implementation efforts in the country. 
Through these examples, this section touches on key themes relevant to potential SCF 
implementation in the U.S., such as the efforts to pass new drug policies and the role of 
the federal court system, along with addressing the overarching barrier that the federal 
law poses to SCF implementation. 
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A. San Francisco, California 
San Francisco, like countless other cities across the United States, has dealt with 
the debilitating impacts of the overdose crisis for decades. In 2007, the Drug Policy 
Alliance (DPA), in conjunction with the Alliance for Saving Lives, began working 
towards the implementation of supervised consumption services in San Francisco.69 
While much of this work was done through advocacy and behind the scenes work, this 
came to a head nine years later, when in 2016, the DPA drafted Assembly Bill 186 (AB-
186) for Assembly member Susan Talamantes Eggman, and co-sponsored by Tarzana 
Treatment Center and Project Inform, that would be brought to the California Assembly 
during the 2017-2018 session.69 Passage of AB-186 would remove and add a section to 
the Health and Safety code that would allow for the opening of “overdose prevention 
programs'' meeting specific requirements including, “a hygienic space supervised by 
health care professionals, as defined, where people who use drugs can consume pre-
obtained drugs, sterile consumption supplies, and access to referrals to substance use 
disorder treatment.”70 While legislative passage of this bill was a large step forward for 
San Francisco harm reduction, AB-186 was vetoed by Governor Jerry Brown71 who 
stated in his veto that he did not believe, “enabling illegal drug use in government 
sponsored injection centers-with no corresponding requirement that the user undergo 
treatment-will not reduce drug addiction.”72 He then reiterated this opinion later in his 
veto note stating, “I repeat, enabling illegal and destructive drug use will never work. 
The community must have the authority and the laws to require compassionate but 
effective and mandatory treatment. AB-186 is all carrot and no stick.”72 Governor 
Brown’s sentiments are incorrect in assuming that drug policies always need a “stick.” 
His beliefs that SCFs enable drug use without offering any means by which to reduce 
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drug addiction, refer PWUD to treatment (if they want it), or ameliorate the morbidities 
and mortalities of drug use and overdose are fundamentally disproven by the evidence 
found through SCF evaluation. This body of evidence helped ensure that efforts towards 
SCF implementation in San Francisco did not die with this veto. 
The veto of AB-186 halted official legislative movement on supervised 
consumption for a time, but the evidence in support of SCFs enabled the advocacy and 
administrative efforts at the city level to continue. San Francisco Mayor London Breed 
has been an open advocate for supervised injection prior to and throughout her 
mayorship.73,74 The Board of Supervisors for the city has also come out in favor of the 
implementation of supervised injection sites and unanimously approved an ordinance 
creating an overdose prevention program for the city.74 After several years of additional 
public administrative support, Senator Scott Weiner re-introduced legislation in 2020, 
as Senate Bill 57, which would allow San Francisco, Oakland, and Los Angeles to pilot 
supervised consumption facilities, with the pilots ending January 1, 2027.75 As reported, 
these sites are to be supervised injection sites, rather than broader supervised 
consumption sites. SB-57 will remove the current state prohibition and allow local 
authorities to decide whether to open safe injection facilities.71 Most recently, SB-57, was 
last amended on March 25, 2021 and was sent to the Senate Committee on Public Safety 
where it passed 4-1 on April 6, 2021.76 This version of the SB-57 has received verified 
support from numerous harm reduction, health justice, legal, and medical organizations 
as well as cities and counties in California with opposition from only a short list of 
entities including some organizations focused on law enforcement, traditional religious 
and family values, and college and university policing.77 The bill has been ordered to 
third reading set to take place on April 20, 2021.76 
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B. New York State and Ithaca, NY 
Like San Francisco, New York has seen movement toward and discussions 
around supervised consumption for years now. While New York City often receives 
much of the coverage coming out of the state, there is also movement in other parts of 
New York, namely upstate in Ithaca. While the push for supervised consumption in San 
Francisco was initially championed by non-profits and community organizations, Ithaca 
Mayor Svante Myrick has been leading the local push for progressive harm reduction for 
the better part of a decade. After speaking at a drug policy conference in 2013, Myrick 
began working with public health and drug policy experts to reform Ithaca’s response to 
drug use and illicit drug market.78 In April 2014, Mayor Myrick convened a meeting of 
key stakeholders to discuss a new strategy with regard to drug use and drug policy, 
including representation from the District Attorney’s Office, police department, fire 
department, the City of Ithaca, the city school district, and service and drug policy 
oriented non-profits and community organizations.78 The process of planning and 
gaining community buy-in continued and throughout 2015, the Mayor held public 
events and focus groups to discuss the new strategy towards drug use and policy in the 
city with community members. These focus groups consisted of law enforcement 
personnel, physicians, nurses, pharmacists, people who use drugs, young people, people 
of color, parents, business owners, and people in recovery.78 The culmination of years of 
work came in 2016 with the publishing of The Ithaca Plan, outlining the city’s new 
approach to drug use and the drug market. Among the recommendations within the 
report was to, “Explore the operation of a supervised injection site staffed with medical 
personnel as a means to: prevent fatal and non-fatal overdose, infectious disease, and 
bacterial infections; reduce public drug use and discarded needles; and provide primary 
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care and referrals to basic services, housing, and substance use services and treatment, 
including the integration of a primary health care provider at harm reduction sites.”78 In 
the Spring of 2017, the Drug Policy Alliance’s project EndOverdoseNY, in conjunction 
with VOCAL New York, The Katal Center for Health Equity and Justice, and the Student 
for Sensible Drug Policy rolled out the “Safe Shape Tour.” This 10-day tour traveled 
around the state of New York and featured a model safe consumption site to give 
citizens an idea of what one might look like.79 Among the stops on the tour was 
Ithaca.79,80  
The push for supervised consumption in Ithaca seemed to be consistent with 
efforts at the state level. In June 2017, New York Assembly Member Rosenthal, with 
members Peoples-Stokes, Gottfried, Skarlatos, Carroll, Lentol and Lupardo as co-
sponsors, introduced Assembly Bill A8534, relating to the enactment of the Safer 
Consumption Services Act.81 In January 2018, A8534 was referred to the Assembly 
Health Committee, the last action taken on this bill.81 Following this, in May 2018, New 
York City Mayor Bill de Blasio called for the implementation of four pilot supervised 
injection facilities in the state and Mayor Myrick immediately asked Governor Cuomo 
for Ithaca to be considered as the location for a fifth site.82,83 Despite this action, 
attempts to move supervised consumption legislatively in New York has borne no fruit, 
with the Supervised Consumption Service Act being reintroduced as A60 and S498 in 
the 2019-2020 session, where it was referred to the Health Committee with no further 
action indicated, and then again as A224 and S603 in the 2020-2021 session, referred to 
the Health Committee on January 6, 2021 with no further action indicated as of yet.81,84–
87 What will come from the introduction of A224 and S603 to the 2020-2021 session is 
still to be seen.  
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C. Philadelphia, Pennsylvania  
Among cities in the U.S. actively pursuing implementation of supervised 
consumption sites, Philadelphia has certainly garnered a large amount of publicity for 
their efforts. Around 2015, a group in Philadelphia called the Sol Collective began the 
hard work of talking with people in a neighborhood of Philadelphia where it was 
hypothesized a supervised consumption site might be located.88 They wanted to start the 
process of community building and gaining buy-in from PWUDs, but also other 
communities members and Philadelphians who would be neighbors to the site.88 This 
work took several years and in January 2018,  city officials in Philadelphia announced 
that they would allow -- but not fund -- a supervised injection facility in Philadelphia.89 
Later that year, Safehouse, a non-profit focused on overdose prevention in Philadelphia, 
became incorporated with the goal of opening the city’s first supervised injection 
facility.89,90 Safehouse brought many Philadelphia stakeholders into the conversation, 
with their Board of Directors including Pennsylvania’s former governor and 
representation from Prevention Point (the city’s only syringe exchange) and the AIDS 
Law Project of Pennsylvania. Safehouse’s advisory board also has representation from 
Drexel’s Dornsife School of Public Health, Temple University’s health system, the 
Department of Behavioral Health and Intellectual Disability Services, and Project 
HOME (a housing, poverty, and homelessness services organization affiliated with the 
Catholic Church).89 
After incorporation, Safehouse, for reasons currently undocumented nor fully 
disclosed, moved the potential location of the SIF to a different part of the city, undoing 
much of the work that had been done by the Sol Collective in the years prior,88 
disrupting relationships that had been made in one part of the city and upsetting 
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community members in a new area of the city that had not been informed or 
consulted.91 Pushback from community members was a formidable obstacle and soon, 
Safehouse faced another major barrier when in February 2019, the U.S. Attorney for the 
Eastern District of Pennsylvania filed a civil suit asking that a federal court declare 
supervised consumption sites illegal under the United States Controlled Substances 
Act.92 As the case proceeded through federal court, it garnered a significant amount of 
attention, potentially due to it being the first case of its kind in the U.S. This attention 
included 132 amicus briefs that were filed, including by 8 states and 6 cities who wrote 
in support of Safehouse, knowing that the implications of this ruling extended far 
beyond just Philadelphia.92 In October 2019, a U.S. District judge ruled that because 
Safehouse would operate with an ultimate goal of reducing drug use rather than 
facilitating it, their operation was not unlawful under the Controlled Substances Act.92 A 
few months later, in February 2020, a final declaratory judgement was issued stating 
that Safehouse could open lawfully, as could any supervised sites that opened after 
Safehouse within the Eastern District of Pennsylvania.92 Just two days after the final 
declaratory judgement was issued, the U.S. Department of Justice filed a Notice of 
Appeal and an Emergency Motion of Stay, asking that Safehouse be prevented from 
opening until after the Third Circuit Court issued their judgement.92 This stay was 
granted and the case was brought to the Third Circuit Court of Appeals92 to be ruled on 
by three judges. Once again, hundreds of amicus briefs were written, the vast majority in 
support of Safehouse, including 85 current and former prosecutors and law enforcement 
officials, 6 cities, and 10 states.92 In January 2021, the Third Circuit court ruled 2-1 
against Safehouse, stating that it is unlawful to open under the Controlled Substance Act 
because, “Safehouse knows and intends that its visitors will come with a significant 
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purpose of doing drugs.”93 At this time, two district court judges have concluded that the 
opening of Safehouse would be lawful and two appellate court judges  have ruled that it 
would be unlawful.92 As of March 2021, Safehouse has filed a petition for rehearing en 
banc, in order to have the case heard by the full appellate court panel rather than just 
three judges as it was before, with support again from numerous amicus briefs.92 
Safehouse maintains that they will not open a site until it is ruled lawful to do so.92 
 
The efforts to implement SCFs in the U.S. have been met with various types of 
barriers and degrees of difficulty depending on the location. Experiences seem to be 
marked by a misunderstanding (or lack of belief) that SCFs are efficacious for the 
reduction of overdose and substance use morbidity and mortality and, in locations 
where bills are currently in the state legislature, that policy change is a long process, 
with bills often bumped from one legislative session to another or one committee to 
another. More broadly, every effort in the U.S. to implement supervised consumption is 
happening under the looming barrier of federal drug policy, an inescapable reality that 
all cities and states looking towards SCF implementation need to contend with.  
VI. Federal Law: A Key Barriers to SCFs in the U.S. 
The examples of SCF implementation globally as well as the attempts being made 
in the United States provide key insights with regard to how one may go about SCF 
implementation. In particular, a lesson learned from Canada was the need to change or 
obtain exemptions in federal policies for a facility like Insite to remain open. This 
remains the case for the U.S., where amendments to federal laws and/or  support, or at 
least tacit permission, from government at all levels are necessary.62 Without one or 
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both of these, there is a high likelihood that implementation at the state or local level 
would be met with legal action from the federal government, as seen in the case of 
Safehouse, with the goal of deeming it unlawful and shutting down the facility.62 Fear of 
federal action amplifies state level resistance.  
Any action taken against SCF implementation would be due in particular to two 
federal U.S. statutes; Sections 844 and 856 of the Controlled Substances Act. The 
particularly relevant part of Section 844 reads, “It shall be unlawful for any person 
knowingly or intentionally to possess a controlled substance unless such substance was 
obtained directly, or pursuant to a valid prescription or order, from a practitioner, while 
acting in the course of his professional practice…”.94 This statute makes drug possession 
illegal and therefore any person who would try to access a SCF in possession of drugs 
would be breaking the law.27 Although Section 844 is relevant to the conversation 
around supervised consumption, the statute that has come up more frequently as a 
concern for the municipal and other local actors with regard to SCFs is Section 856, 
colloquially known as the “Crack house Statute,” which reads, “....it shall be unlawful to 
(1) knowingly open, lease, rent, use, or maintain any place, whether permanently or 
temporarily, for the purpose of manufacturing, distributing, or using any controlled 
substance; (2) manage or control any place, whether permanently or temporarily, either 
as an owner, lessee, agent, employee, occupant, or mortgagee, and knowingly and 
intentionally rent, lease, profit from, or make available for use, with or without 
compensation, the place for the purpose of unlawfully manufacturing, storing, 
distributing, or using a controlled substance.”94 Although proponents of SCFs argue that 
this statute was never meant to be applied to legally authorized public health 
interventions and therefore should not be used to infringe upon a state’s rights to 
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implement public health initiatives,27 this has been the primary argument utilized by the 
plaintiff in the United States vs. Safehouse case.93  While the Biden administration’s 
justice department is untested in regard to this specific issue, it is expected that in the 
future, if federal laws or sentiments around supervised consumption do not change, any 
entity that tries to implement a supervised consumption facility could meet the same 
legal action as Safehouse.  
VII. A Qualitative Study of the Potential for SCF Implementation 
in New Haven, CT 
 
 Keeping this background information in mind as context, this thesis seeks to 
provide an understanding about the barriers and facilitators to implementation of 
supervised consumption facilities in New Haven, as well as determine the current 
climate of opinions, understanding, and will for sanctioned implementation. Activism 
and actions outside of the law in the United States have led to operating unsanctioned 
SCFs across the country, including in the state of Connecticut, that are operating daily to 
provide PWUDs with safer environments in which to use substances.17 This thesis 
presents additional local view points as part of promoting a productive public discussion 
of what it would take for sanctioned sites to open, especially given the advantages that 
legality provides, including the ability to serve more people, to staff a site with licensed 
clinicians, create coordination with other services providers, and obtain funding to 
expand services and operating hours, all made possible by removing the threat and 
reality of criminal penalties for implementing a SCF.17 This qualitative study lends itself 
to the inclusion of greater detail, that cannot be captured by quantitative data alone, 
pertaining to the climate around harm reduction in New Haven and provides space for 
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key informants to further explain the opportunities for SCF implementation specific to 
the current context of the city.  
 
A. Conceptual framework 
With the overlapping and interwoven possibilities and complications that can 
come along with the implementation of a SCF, it can be very important for enacting 
entities to be highly opportunistic. Given these potential challenges, those looking to 
implement SCFs need to account for current political climates, the policy options that 
come with them, and how the public conceptualizes the problem of drug overdose, in 
order to determine if an opportunity for supervised consumption presents itself or can 
be made. John Kingdon’s Multiple Stream Theory, outlined in his book, “Agendas, 
Alternatives and Public Policies,” 5 provides a framework that informs when a moment 
in time and space may be particularly opportune for policy change. Although the theory 
more broadly applies to determining when politicians are most likely to enact policy 
change in general,95 it translates well when thinking about the space for, and the kinds 
of issue streams that could contribute to, the potential for SCF implementation. 
Kingdon argues that policy change is most likely to occur when there is an alignment of 
problems, policy options, and political circumstances.95 In order to determine if an 
opportunity for policy change regarding supervised consumption is present in New 
Haven, I draw from theorists who have argued that these three streams aid in 
understanding why some governments manage to legally sanction SCFs and others do 
not.95 When problems, solutions, and politics align, a “window” opens to allow for policy 
change to occur.5 Steven Hayle has applied Kingdon’s Multiple Stream Theory to assess 
how SCFs were able to be opened in Canada but failed to be implemented in England 
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and Wales.95 The analysis portion of this thesis puts this into practice for New Haven, 
CT and will explore, among other things, how responses from key informants reflect the 
current framings of the problem, policy options, and political circumstances in the city 
to help determine if now, or soon, may be a particularly opportunistic time to try to 
implement SCFs. The themes extracted from key informant interviews highlight the 
current political climate of the city, state, and country, the presentation of supervised 
consumption as a policy option, and the ways in which different groups view drug 
overdose morbidity and mortality as a problem. The data contained within these themes 
converge to implicate a window of opportunity for SCF implementation.  
 
B. Methods: Qualitative study with local key informants 
 This thesis presents a  qualitative study, carried out through semi-structured 
interviews with key informants (n = 9) who have knowledge of the service provision and 
harm reduction landscape and climate in New Haven and the state of Connecticut. This 
study was granted a Category 2 exemption by the Yale Institutional Review Board and is 
considered Not Human Subjects Research. Key informants were recruited for this study 
through email. A full script of the recruitment email can be found in Appendix A. 
Interviews were conducted via video call over Zoom, recorded, and then transcribed. 
The full qualitative interview guide can be found in Appendix B. Upon transcription, 
recordings were deleted, and transcriptions were anonymized and edited to remove all 
identifying information in order to protect the identities of key informants. Interview 
transcriptions were then qualitatively coded using Dedoose software and themes were 
identified, including but not limited to the facets of Kingdon’s Multiple Stream Theory, 
as well as facilitators and barriers to SCF implementation in New Haven. Upon 
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completion of the first round of coding, the qualitative codebook was refined and then 
all interview transcripts underwent a second round of coding to ensure the codebook 
was appropriately applied. 
 
C. Findings and Analysis: Understanding Barriers and Acknowledging 
Opportunity  
 
Qualitative coding identified seven thematic parent codes which make up the 
skeleton of this analysis; barriers, facilitators, next steps, policy options, 
problematization, political circumstances, and “keep in mind,” a code devoted to other 
important facets of implementing a SCF in New Haven that should be kept in mind but 
that did not neatly fit into other code buckets. Barriers, facilitators, and “keep in mind” 
all contain subcodes that identify more specific aspects of the theme that were brought 
up on numerous occasions by key informants. For a full description of the parent codes, 
subcodes, as well as inclusion and exclusion criteria for each, see the qualitative 
codebook in Appendix C. This section highlights the themes of barriers and facilitators, 
considered alongside each facet of Kingdon’s Multiple Stream Theory, to make visible 
the ‘streams’ which can be usefully identified to see the possible spaces for action 




 Key informants were asked to specifically identify barriers to the implementation 
of SCFs in New Haven, CT. For coding, “barriers” were defined as, “Anything that may 
hinder the process of implementation of supervised consumption services in New 
Haven.” Within the broader parent code of “barriers,” subcodes were identified due to 
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the ways in which they were implicated by multiple key informants. The subcodes 
identified were labeled as PWUD organizing, location, stigma, resources/money, and 
Yale. The final part of this section highlights additional barriers that were mentioned 
less frequently by key informants but contribute to the multifaceted complexities of SCF 
implementation in New Haven. Naming these barriers provides additional 
understanding of influential factors that challenge SCF implementation.  
 
Barrier -- PWUD Organizing 
 
 Key informants identified that a lack of social and political organizing or 
unionization of PWUDs in New Haven may be a barrier to the implementation of SCFs 
in the city. This likely stems from the knowledge that the organization and/or 
unionization of PWUDs can and has been instrumental in the implementation of SCFs 
in the past, such as in the case of the Vancouver Area Network of Drug Users (VANDU) 
and the opening of Insite.51  
“And there's that kind of community organizing piece that you know, as I 
mentioned, starting out is absent here and frankly I think it's to the detriment of 
any effort to potentially move forward with not just a supervised consumption site 
but I think meaningful scale up of any type of intervention.”96 
 
This informant went on to elaborate on why the lack of unionization or organizing can 
become particularly problematic.  
“Space needs to be seated to community in a meaningful way, and that's not just 
here that's so many places, but, without drug user organizing happening there's 
really no accountability in that and it becomes really easy to go forward without 
that meaningful engagement or to find ways to frankly shoehorn it in, in really 
tokenistic ways.”96 
 
Other key informants indicated this lack of organization or unionization of PWUDs in 
New Haven as a barrier by comparing the city to others in the U.S. where advocacy 
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organizations made by and for PWUDs have been created and have been influential in 
harm reduction discussions.  
“In San Francisco they have like a drug users union for people with lived 
experience, and I think there was more of a progressive conversation on harm 
reduction there compared to New Haven, where a lot of the conversations in New 
Haven are driven by well-intentioned people like myself, but who aren’t people 
[with] lived experience or active drug users, using the services. There's more 
conversations being driven by service providers and not by drug users, which is 
something I've always noticed in New Haven.”97 
 
The lack of PWUD organizing in New Haven contributes to a maintenance of the harm 
reduction status quo and is juxtaposed against the reality that PWUD unions have 
helped move the needle on harm reduction in other cities and countries. The influence 
of PWUD organizing on the success of SCF implementation in the past provides 
credence to the idea that a lack of PWUD organizing in New Haven is a current barrier 
to implementation. Although there is work being done to begin the organizing of PWUD 
in New Haven, no group has been fully developed or included meaningfully in harm 
reduction efforts in the city.  
 
Barrier – Location 
 
 Many key informants brought up the issue of location as a potential barrier to 
implementation. In postulating about where a SCF would be located in the city, as well 
as the process that would ensue in selecting a location, many key informants indicated 
strong tensions developing across groups in New Haven.  
“I think they're gonna be enough people [who] want to try it, but I think where it 
is sited is going to be the biggest fight. I mean that was true in Philadelphia as 
well, where I think a lot of the debate was between the neighborhood and where it 
was going to be located and then I think that is really going to be where the 
rubber hits the road.”97 
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Importantly, one informant noted how the surfacing of these tensions could result in 
open organizing and advocating against a SCF in New Haven. 
“Siting could be highly political. You could have organizing against it, because 
that happens places and then you just go forward anyway. I mean a lot of these 
are just the barriers that happen in any other community that implements a site 
right like, business owners organized against them, church groups, concerned 
citizens like, this has happened so many places that have appointed a site.”96 
 
In addition to tensions around siting a SCF in New Haven, several key informants also 
indicated that selecting a location may be a barrier by nature of that fact that choosing 
an appropriate location or locations may be more difficult in the city.  
“And that there are sort of a variety of pockets and areas where you might site 
such a such a facility….In New Haven you have the lower density, it may be 
distributed across a variety of geographic locations and making a decision about 
where to site such a facility is a public health and sort of scientific challenge to 
improve the return on investment.”98 
 
“Geographically, what does this look like in New Haven, given the kind of 
dispersion of the local drug using population, how it's racially kind of segregated 
in some ways, and what that means for what a site or service might look like? You 
know that's a big thing to figure out, especially within the context of what type of 
site becomes possible.”96 
 
The difficulty and potential barrier of selecting the location of a site or multiple sites for 
SCFs in New Haven harkens back to the example of SCF expansion in Canada. The 
model of a single site in Vancouver did not necessarily make the most sense when 
applied to other cities and therefore, these individual cities needed to overcome the 
barrier of figuring out locations and models that worked for the needs of PWUDs in 









Barrier – stigma 
 
 Another highly relevant barrier indicated by key informants was the role that 
stigma still plays when considering substance use and harm reduction for PWUDs. This 
stigma, especially “not in my backyard” (NIMBy) sentiments, can influence policies. 
“I think there’s NIMByism. I think that there’s deep down, there’s just really 
significant cultural hostility and hatred of people who use drugs. Hostility, 
hatred, blame, shame of people who use drugs and that gets written into local and 
state ordinances.”91 
 
Some key informants noted how stigma still has a direct link to the criminality of drug 
use. Given the fact that SCFs give space for people to use substances, the criminality that 
is deeply tied to stigma poses a barrier to implementation. 
“Well, we haven't shifted people's thinking about drug use in general, and I think 
that's the sort of the main barrier in terms of looking at that, because it is ‘drug 
use is bad’ and ‘everybody who uses drugs is a criminal,’ right, and ‘the goal is to 
have them stop.’ And ‘the goal is to arrest in order to make them stop.’”99 
 
If the focus is on criminalization and not the health and well-being of PWUDs, the 
argument for SCFs can be particularly difficult to make. Finally, key informants touched 
on the role that internalized and self-stigma plays in the lives of PWUDs. The role that 
self-stigma plays in certain substance use behaviors, and as a barrier to altering those 
behaviors, cannot be underestimated. 
“There’s a lot of self-stigma. The role of self-stigma in some populations is really 
deep and it leads to people using alone more so or in really small, you know 
confined settings.”100 
 
Stigma towards and internalized by PWUDs is still highly salient and deeply rooted in 
the city of New Haven. If the city is to implement a SCF, there is much work to be done 
to overcome this barrier, among PWUDs and others in the community, including but 
not limited to residents, service providers, and physicians.  
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Barrier – resources/money 
 
 A lack of resources and money was identified by key informants as a barrier to 
the implementation of a SCF in New Haven. Without appropriate funding and 
resources, it would be incredibly difficult to implement a SCF. Informants indicated that 
these much-needed resources and funds may not currently be available.  
“New Haven’s broke, right. Like it's going to cost money to fund and implement a 
site, particularly if people have in mind that it needs to kind of like…so this has 
always been the danger of Insite [REDACTED]....it reinforced for people that, 
‘Oh, we need [a] nursing station, nursing resource room, booth set up in this way, 
we need this footprint, we need the staffing compliment.’ That costs money and 
New Haven has no money.”96 
 
Without appropriate and sustainable resources and funding, any entity in the city would 
face difficulty opening a SCF.  
 
Barrier – Yale 
 
 The presence and influence of Yale in the New Haven space was indicated by key 
informants to have advantages and disadvantages contributing as facilitators and 
barriers to implementation of supervised consumption services. This theme specifically 
explores the impact of Yale as a potential barrier, with its role as a facilitator explored in 
the following section. Key informants indicated that there are attributes of Yale and its 
omnipresence in New Haven that would strongly contribute as a barrier to SCF 
implementation. There are ways in which Yale may stand politically and structurally 
opposed to supervised consumption.  
“I think Yale is huge. I mean they are absolutely a little “c” conservative entity. 
They kinda got a good game going and they don't want to mess it up. They're 
looking for the long term, they don't want to do any big changes. I mean, 
arguably, a big “C” conservative entity as well. I think they are absolutely. It's not 
going to be located on Broadway, not that that would be the right place, but you 
can think Yale’s push. I mean, a place like Broadway is kinda like a mall. It's like 
they would rather have like empty storefronts on Broadway then have something 
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that's not a Lululemon. And putting a safe consumption site in New Haven is 
absolutely not in line with that that type of vision for the city.”97 
 
In thinking back on the issue of a lack of resources for the implementation of a SCF, key 
informants also indicated that Yale may serve as a financial barrier as well.  
“Yale’s a leech in New Haven. It's simultaneously destroying the municipal tax 
base, while not meaningfully step[ping up] to the plate to address rampant 
inequity. And you know, Yale could probably do a lot more to move these things 
forward by getting out of the way and, just like paying its fair share New 
Haven.”96 
 
Lastly, the relationship between Yale and the New Haven community, a relationship 
that has been marked by tension and perceived elitism of Yale by the community, may 
serve as a barrier to the implementation of a SCF in the city.  
“That's where the town-gown dynamic comes in and the reason why I bring it up 
is that I think actually a lot of harm reduction initiatives would be generally 
popular in New Haven if people in the Yale community can do a better job 
bridging that town-gown divide….my impression was there was some 
unnecessary division, because there was an impression that we have Yale elites 
sticking their noses up at the people who are scared…. that dynamic creates 
missed opportunities for broader acceptance and interest in harm reduction 
beyond the Yale community in New Haven.”101 
 
The role and influence of Yale in New Haven is undoubtable. If Yale were to position 
itself in opposition to something like a SCF in New Haven, the power that Yale wields 
would stand firmly as a barrier to implementation.  
 
Additional Barriers  
 
 In addition to the thematically coded barriers above, there were other barriers 
mentioned less frequently by key informants, but that my review of the literatures and 
the contextualized global and national stories of SCFs suggest are still highly relevant as 
specific barriers to implementation of SCFs in New Haven. A barrier that came up 
infrequently but is highly relevant is the federal law and legal barriers in place that can 
 44 
be employed in opposition of supervised consumption, namely the Controlled 
Substances Act. The federal regulations and legal barriers may have come up 
infrequently due to the fact that the interview questions asked specifically about barriers 
in New Haven. However, although the implications of the federal law are not exclusive 
to New Haven, they inevitably influence the implementation of a SCF, as one informant 
very bluntly noted, “There are federal regulatory barriers, including the Department of 
Justice, that are a barrier.”98 In thinking about how to navigate the barriers of federal 
law, there seemed to be a mentality that there either needs to be policy change or there 
needs to be the will to work without it.  
“So, you know structural level, I mean we need federal policy change or we need 
political courage to ignore the need for federal policy change and for someone to 
just go ahead. And either of those could work.”96 
 
Although it was not mentioned as frequently as other barriers, federal policy and legal 
barriers are some of the most serious threats looming over supervised consumption and 
harm reduction more broadly. While political courage may be needed to “just go ahead” 
and move forward with opening a site, this does not overcome the overarching threat 
and presence of federal opposition by way of the Controlled Substances Act.  
 Another less frequently mentioned barrier that holds weight in New Haven is the 
role of policing. For decades, New Haven has seen policing trends which reflect a false 
idea that police are enforcers of publicly understood morality, rather than the law.102 In 
cases where new, more progressive, leadership is appointed, there is often a gap 
between what those leaders say and what is actually practiced by the rank and file 
officers throughout the city.102 This becomes highly relevant when thinking about how 
drug use, overdose, PWUDs are moralized and stigmatized in New Haven, effectively 
dictating how they are policed. In addition to trend policing and inconsistencies 
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between what leadership says and what is done, the presence of police in New Haven is 
incredibly strong, with the New Haven Police Department (NHPD), Yale Police 
Department (YPD), and Hamden Police Department (HPD) making up the “Triple 
Occupation” of New Haven.103 This “Triple Occupation” results in opacity with regarding 
to conduct of officers and the surveillance of people in New Haven. These police forces 
have an amplified presence in the city due to the number of officers per capita totaling 
around or above the national average (2.4 officers per 1000 residents),104 with HPD 
employing 1.7 officers per 1000 residents, NHPD employing 3.1 officers per 1000 
residents, and YPD employing 6.7 officers per 1000 students.105,106 The number of 
officers across all three police departments totals 601 officers in the city.105,106 If 
members of these police forces are in opposition to the implementation of a SCF, they 
too would serve as a very tangible barrier in the city.  
“I think the challenge is, among the police department, the police Union and 
some of these working class communities, that town-gown divide is still a danger 
because they think they're…it can get caught up in the larger cultural upheaval of 
the moment and people who might otherwise be open to more humane treatment 
of people with addiction, if it gets polarized, you know [in the] culture wars of the 
moment, it could it could cause people who might be willing to consider change 
becoming resistant and kind of reactionary way.”101 
 
The policing of PWUDs in New Haven could certainly translate into a policing of any 
sort of SCF that would be implemented in the city. Police could very well serve as a 
barrier to implementation, as well as a barrier to access for PWUDs, if a facility were to 
be opened.  
 
 A final barrier indicated by a key informant that is highly relevant to the 
discussion around SCFs in New Haven is the language used to describe the intervention.  
“The messaging cannot be ‘safer use site’… the appetite exists for ‘overdose 
prevention.’ That is the public health framing that has been suggested very 
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heavily. Because, then it is a preventative measure, it is proactive. And it focuses 
on solving the end problem, not providing the means that could lead to an 
overdose. It's like a little psychological and political framing switch, but I think 
it's telling of what those folks have an appetite for.”88 
 
Any potential for SCFs in New Haven could be halted before implementation was even 
able to begin if those working towards implementation were to use language that was 
not palatable to people within the city and at various levels of government. Thinking 
critically and strategically about language is highly important, and using what may be 
deemed by others as the “wrong language” stands as a firm barrier to implementation.  
 The barriers elucidated by key informants provide critical insight into what is 
imperative to be thinking about in movement towards implementation of a SCF in New 
Haven. Any entity interested in progressing on supervised consumption in the city 
would want to consider how these barriers are addressable, in the current moment and 
through coordination with specific allies, in order to move forward.  
 
C2. Facilitators  
 
While it is critically important to identify obstacles, it is also crucial to note what 
resources are already established that are beneficial, here noted as facilitators. For 
coding, “facilitators” were defined as, “Anything that may serve to help the process of 
implementation of supervised consumption services in New Haven.” As was done with 
the barriers, subcodes within the broader “facilitators” code were identified due to the 
ways in which they were implicated by multiple key informants. The subcodes identified 
were labeled as need, New Haven taskforces, organizations, the Vital Strategies Grant, 
and Yale.  
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Facilitator – Need: recognition of the overdose deaths as ‘tip of the 
iceberg”—and preventability of death 
 
 Many key informants specifically named “need” as a facilitator which could 
support initiatives to provide supervised consumption services. This need, as recognized 
by key informants and other parties within the City of New Haven, serves as a backdrop 
to the potential for SCF implementation. This need is characterized not only by overdose 
deaths but by any and all other harms incurred when the health and well-being of 
PWUDs are not prioritized.  
“I think the other thing that supports this is the relative ongoing challenge and 
ongoing rise in opioid overdose deaths. You know, those numbers are not 
changing in the right direction, and so that supports looking for additional 
strategies… I always think it's important to recognize it's kind of the tip of the 
iceberg. That for every death, there's so many other individuals who are suffering 
or experiencing harms related to opioids and potentially not accessing treatment. 
They're impacted, their families are impacted…. the numbers continue to 
increase, and so it means that there needs to be consideration of other strategies 
that have evidence of effectiveness in other jurisdictions.”98 
 
This need is also characterized by the continued harm and death that is entirely 
avoidable.  
“The safe consumption sites are absolutely necessary. I’ve lost so many clients…. 
These are completely preventable if there was a site. So, I mean, it's just 
unquestionably necessary and you see the numbers that come out of Quinnipiac 
Valley Health and every week it's just 30 or more now. It didn't used to be like 
that. So, to give people the opportunity to live and just be in a safe place. It’s 
huge.”107 
 
It is evident that there is a pressing need for additional interventions for PWUDs in New 
Haven. However, if need were enough, movement on harm reduction in the city would 
have progressed far beyond where it is currently. Nevertheless, the understanding of 




Facilitator – New Haven Taskforces as making space for action 
 
 In recent years, the City of New Haven and Yale have convened several 
complementary taskforces to discuss harm reduction and the overdose crisis in the city. 
Many key informants saw these taskforces as facilitators to the potential 
implementation of SCFs in New Haven. Several key informants credited Gregg 
Gonsalves, a professor at the Yale School of Public Health, Yale Law School, and devoted 
harm reductionist, to bringing these taskforces together in a beneficial way.  
“I will say Gregg has done a great job of sort of getting people in the same room 
and starting to have sort of conversations together, because I think they've been 
an opportunity where, for example, we knew SWAN existed….but I never like sat 
in a room with them. But now I can say, ‘Oh I’ve been on phone calls with them, 
I’ve sat in a room.’ So, I think that effort that Gregg and company have done to 
start having people together and meeting and talking has been very helpful…. 
people are meeting and service providers are meeting with researchers, are 
meeting with potentially some people in the city to try to move these 
conversations forward.”97 
 
Importantly, many people on the taskforces work to ensure that when talking about 
health and health services in the city, PWUDs are being considered.  
“Well, I mean things are already happening right, where Gregg Gonsalves is 
leading the harm reduction group and holding meetings and getting the input of 
experts who then say, ‘Oh, we can't forget about people who use drugs,’ and want 
to have them included which I agree with, and is critically important.”100 
 
These taskforces do work to have the ear of people throughout different parts of Yale, in 
different service organizations, city departments, and city government. Their presence 
and emphasis on centering the needs and health of PWUDs is a crucial facilitator in the 
New Haven landscape.  
 
Facilitator – Organizations 
 
 Adjacent to the New Haven taskforces serving as facilitators, key informants also 
indicated that organizations in New Haven serve to facilitate potentially successful 
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initiatives of SCF implementation in the city. The culture of harm reductionist 
organizations in New Haven helps bolster the culture around harm reduction 
frameworks and serves as a facilitator for new interventions.  
“I've worked at the APT foundation in the past, and I think at it's very core, it is 
very harm reductionist. You know being open access as a[n opioid treatment 
program] is harm reductionist. They have had that sort of influence in New 
Haven, in setting a really high bar for what we ought to expect out of OTP in 
having good access to treatment. I've worked with SWAN…I think that they work 
closely with Cornell Scott and Phil Costello who does their kind of medical care 
and I think they've been big proponents of just meeting women who have 
transactional sex where they are. I think that's harm reduction.”100 
 
Other key informants reinforced the role that the APT Foundation plays in the city and 
how their presence and mission serve to facilitate the potential for SCFs.  
“So APT Foundation has always been a leader in, frankly not just locally, but 
nationally sort of taking these types of strategies and incorporating them in the 
treatment that they provide to patients who use substances. It's hard to 
underestimate the value of a local community based organization and treatment 
facility in supporting these types of efforts.”98 
 
As stated by key informants, having support from established community organizations 
will be beneficial to any movement on the implementation of SCFs in New Haven. With 
a wide variety and amount of service organizations in the city, the impact that buy-in 
from community organizations could have would be a strong facilitator.  
  
Facilitator – Vital Strategies Grant  
 
In 2020, the City of New Haven received a grant from Vital Strategies, Inc., a 
global Bloomberg affiliated non-profit, that, “helps communities address substance-
abuse crises through ‘harm reduction’ strategies.”108 This grant placed Christine 
Rodriguez in New Haven to work full-time for the city coordinating the work of harm 
reduction focused groups as well as, “city government-run efforts through a new Harm 
Reduction Task Force, operated under the aegis of the city’s Community Services 
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Administration.”108 Many key informants saw this grant and this new role as a facilitator 
to moving the needle on harm reduction and on supervised consumption in New Haven.  
“I think, with Vital Strategies, placing somebody in tandem with the city, 
somebody like Christine Rodriguez who is well versed, I think that's a huge step 
and so that's incredibly hopeful. And really just hope that as she integrates herself 
into the political machine, it becomes more accepted to for us to push those 
envelopes. I know the conversations are happening.”107 
 
The work, efforts and mission of the grant and the coordinator position seem to 
resonate with city administration, including the Community Services Administrator, Dr. 
Mehul Dalal, which additionally serves as a facilitator.  
“Well I’ve found the city scene to be very interested and I’ve spoken with Dr. 
Dalal and Vital Strategies had previously picked, and has hired, Christine 
Rodriguez to help the city roll out some harm reduction strategies, which is 
incredible.”91 
 
By accounts of key informants, this grant and the coordinator position serve to facilitate 
opening doors and pathways to potentially new harm reduction services in New Haven, 
inclusive of SCFs.  
 
Facilitator – Yale 
 
 As previously noted, Yale was indicated as a facilitator to the potential 
implementation of a SCF in New Haven in addition to its role as a barrier. The 
advantages that Yale provides to the effort around SCF implementation reflect ways in 
which Yale can use its influence and power in New Haven in a way that is, hopefully, less 
exploitative and more helpful. Many of these facilitators indicated by key informants 
centered around Yale’s research capabilities and the “forward thinking” people currently 
at Yale100 who are committed to harm reduction work.  
“So, the group of people at Yale, there’s a very interesting and wonderful group of 
people at Yale that are dedicated to researching harm reduction and care about 
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the principles and practice of it on kind of a city and a state level. So that’s really 
exciting.”91  
 
While research can quickly become exploitative and problematic, the fact that there are 
researchers at Yale devoted to practicing research in way that is inclusive of and born 
from harm reduction principles stood out as a facilitator. Additionally, some informants 
spoke more broadly of the resources that Yale brings to the city.  
“New Haven, it's like many other American cities, but the unique thing, of course, 
is that Yale University is here. Which is very big….It provides opportunities for 
New Haven because it brings resources here in New Haven that wouldn't 
otherwise be here because Yale’s here.”101 
 
The draw that Yale has for people and resources has the potential to be highly beneficial 
as a facilitator for the implementation of SCFs in New Haven, as long as it continues to 
draw in people and resources with harm reduction principles centered in their practice.  
 
C3. Next Steps  
 
 During the semi-structured interviews, key informants were asked to share what 
they believed were crucial next steps to moving forward with the implementation of a 
SCF in New Haven. For coding, “next steps” was defined as, “Important next steps to 
take towards the implementation of supervised consumption in New Haven.” Given the 
current landscape of facilitators and barriers present in the city, key informant 
interviews provided insight into what needs to start happening as soon as possible in 
order for the needle to begin to shift towards SCF implementation. One crucial next step 
identified by key informants was relationship building and getting buy-in from various 
different communities within New Haven.  
“So, I think literally the step would be a public conversation. I don't know if this 
conversation has ever taken place, but even the term harm reduction feels like 
not everyone knows what that means or could identify with that, and so I think a 
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public conversation on what it is, the different faces it could take, different things 
that are done around the country and then really getting buy-in.”100 
 
In addition to having conversations with the general public, communities of New Haven, 
and people who may be directly impacted by the implementation of a SCF, key 
informants also identified the need to get more groups of people involved.  
“You'll need buy-in from community leaders, buy-in from government leaders, 
buy-in from treatment providers, probably buy-in from sort of the standard 
routine health care providers, including the emergency medicine or the 
emergency medical services, as well as the hospital to at least be permissive. So 
there needs to be a shared perception that this is worth pursuing and of potential 
benefit.”98 
 
While some key informants keyed in on the need for relationship building and public 
conversations as next steps, others felt that the most crucial way forward was to just do 
it.  
“Figure out what the model is and just do it. Is it a standalone site? Is it a van? I 
mean honestly it probably should be a van, like a repurposed RV? Because that 
would probably make the most sense, or is it two of them? Get someone to give 
you the money and just…Fuck it just do it. Don't spend the next two years, doing 
feasibility studies and community engagement or anything else, people are dying 
just go ahead. I don't see the point of waiting around stuff like this anymore. 
Right like it's...wait and hope it becomes popular enough to actually do? No, just 
do it. Demonstrate that it works.”96 
 
Although the “just do it” mentality may be in stark contrast to the framework of 
relationship building, it speaks to the perception that there is a drastic need for a change 
in a very immediate sense. Whatever the next steps are to be taken, it is clear from the 
key informant interviews that this process needs to start as soon as possible.  
 
C4. The Sine Qua Non of Meaningful Policy Change: Policy option, 
Political circumstances, and Problematization 
 
 The facilitators and barriers highlighted by key informants provide 
contextualization to how certain institutions, individuals, and frameworks are situated 
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and interact in New Haven. The following three sections discuss how the landscape in 
New Haven can be analyzed through Kingdon’s Multiple Stream Theory based on 
responses from key informants.  
 
C.4.1 Policy Option  
The concept of a “policy option” represents one of the three key facets of Kingdon’s 
Multiple Stream Theory that this study examined in relation to the New Haven context. 
It would be impossible for supervised consumption to be implemented in the city if it 
were not seen as a meaningful policy option. However, responses from key informants 
appeared to indicate that supervised consumption is very much on the table as a policy 
option in the city, as even proposed by current Mayor Justin Elicker. 
“The city's relatively receptive around harm reduction right now, and I think that 
creates a unique space that could allow for scale up of more comprehensive harm 
reduction approaches that exist elsewhere. Certainly the mayor ran on a platform 
that included potentially supervised consumption sites and that's a rare thing in 
any community…I mean you definitely say that about the U.S.”96 
 
“As far as like municipal entities, there's been some really great movement 
among kind of senior officials in this administration….So hopefully we'll be 
seeing some movement around that. Just the fact that they're willing to say the 
words safe use site is important.”88 
 
Additionally, the importance of movement towards supervised consumption as a policy 
option in other cities across the country cannot be understated. Key informants 
indicated that the discussions of supervised consumption as a policy option elsewhere 
enabled it to be a policy option in New Haven as well.  
“There's a momentum thing that happens around supervised consumption as a 
policy response that creates a reality in which it can even be discussed as a 
potential meaningful solution to an overdose crisis. So it's being discussed in 
Seattle, San Francisco, New York, Boston, all of these other cities, I think, creates 
a space where New Haven can talk about it and I would say, even more so within 
kind of the network of progressive ideas around intervening around substance 
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use like, it's kind of positioned in that way and understanding how supervised 
consumption can be located within these kind of international idea networks in 
the substance use space is worth considering.”96 
 
Situating supervised consumption as a policy option is crucial to the potential of SCF 
implementation. Based on responses from key informants, it appears that supervised 
consumption is highlighted as a policy option in New Haven and, if aligned with the 
other two streams, it serves to set the city up for policy change, according to Kingdon’s 
theory. 
 
C.4.2 Political Circumstances 
 Along with the need for supervised consumption to be considered a policy option, 
Kingdon also indicates that in order to see policy change, there must be conducive or 
aligned political circumstances.5 With regard to New Haven specifically, key informants 
indicated, as in the case of policy options, that there seems to be a conducive political 
climate for talking about SCF implementation.  
“Harm reduction practices all of a sudden became mainstream public health 
practices, endorsed by a wide variety of stakeholders and that has provided 
legitimacy to a variety of harm reduction practices. So I guess, I would say that of 
late, there seems to be a greater endorsement and support for harm reduction 
activities.”98  
 
While some key informants reported political circumstances that seemed aligned with 
the potential for SCF implementation, others were more skeptical.  
 
“So, I think the conversations that are being had are really good and everybody 
means really well but, at the end of the day, it seems like the political climate is 
what dictates and being in Connecticut, as much as people like to think it's blue, 
it's purple. So we are where we are….But, there's the entrenched morality that 
hinders politicians, specifically from making good policy decisions and putting 
forth good policies to kind of expand the services that are globally known to have 
incredibly positive outcomes for a significant amount of people.”107 
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Finally, many key informants also noted, importantly, that New Haven is situated within 
a broader political and cultural context that underwent distinct changes in the past year.   
“In this country, cultural change is afoot and fingers crossed hopefully for the 
better. The broad social awakening about racism and structural racism nationally 
and also in New Haven, overall helps the cause of promoting harm reduction, 
because of the way that addiction, especially in cities, historic cities where black 
populations migrated generations ago…there's a convergence of interest. I do 
think that the awakening that's happening right now around racial justice does 
present opportunities….the reason why presents opportunities, it's putting more 
pressure on politicians and institutions.”101  
 
The current political circumstances in New Haven may lend themselves to alignment 
with the two other key features identified as key within the Multiple Stream Theory, 
especially with the positioning of supervised consumption as a policy option. Lingering 
skepticism regarding favorable political circumstances is telling and the future of SCF 
implementation in New Haven may rely on ensuring that these circumstances 
appropriately align.  
 
C.4.3 Problematization 
 The third and final facet of Kingdon’s Multiple Stream Theory rests on the idea of 
“problematization,” or the terms under which an issue is framed as a specific kind of 
problem (e.g., a problem of health, of morals, of good will, of law, etc.). While having the 
appropriate policy options and political circumstances are imperative for potential 
policy change, they are somewhat moot without the issue being problematized in a way 
that allows for connection to the changed political circumstances and policy options. In 
the case of supervised consumption, overdose and the morbidity and mortality of the 
overdose crisis needs to be problematized in such a way that lends itself to identifying 
supervised consumption as a helpful tool, as drug use and overdose as a problem of 
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health rather than morality, and is in alignment with the other two steams, policy 
options and political circumstances. Key informants characterized exactly how the 
morbidity and mortality of the overdose crisis are problematized, including how they 
problematize these issues and how others see them. One key informant problematized 
the issue by expressing their shock at the data:  
“I mean a lot of people are dying in Connecticut, right? Like it's a crisis and I 
don't think we can separate out things that might set conditions for this by not 
first recognizing…I think I saw the data today and I was struck by how many 
people have died. It's a super high overdose rate and it's completely addressable. 
Fentanyl obviously is a game changer because it terrifies people.”96 
 
Although key informants, who have experience and expertise in substance use and harm 
reduction, may problematize these issues a certain way (i.e., as public health problems), 
they also provided insight into how other members of the public may view these issues.  
“I think for the sort of the average person they just don't know that information 
and all the messages they've received are, ‘drugs are bad,’ and the other thing is 
this hierarchy of drugs right like...that those of us who go and buy alcohol on a 
Friday and have some cocktails and all that sort of culture around drinking...like 
they see that so differently than they would see somebody sniffing or shooting 
heroin or fentanyl.”99 
 
By comparing the widely accepted use of alcohol to the far less widely accepted use of 
other drugs, like heroin and fentanyl, we can see how the general public may 
problematize issues around substance use a product of the use of certain “bad” drugs. 
This type of problematization may set back efforts towards SCF implementation as it 
leans on morality and crime as the key features of the problem. Finally, other key 
informants indicated how the problematization of substance use and addiction has 
historically not mirrored the way medicine has problematized other conditions.  
“Historically there's an expectation that there's only one appropriate outcome for 
people who use substances and that's abstinence and anything short of that is 
permissive of ongoing substance use. That reflects a mindset that's completely 
inconsistent with the way we view depression, depressive symptoms, even 
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schizophrenia and schizophrenic symptoms. But certainly more mainstream 
medical issues such as diabetes, high blood pressure, heart disease, all of those 
things, we recognize that our efforts to treat the conditions acknowledge that 
there's going to be some ongoing symptomatology or pathology.”98 
 
The way in which the overdose crisis is problematized greatly contributes to the 
feasibility for SCF implementation in New Haven. While key informants and certain city 
actors may have problematized the crisis in a way that is usefully aligned with the 
current political circumstances and supervised consumption as a (health) policy option, 
key informant responses also indicate that there is work still to be done, on both a small 
and large scale, to create synergy of problematization across multiple groups of people. 
A widespread shift in the public perception of drug use and overdose to one the reflects 
them as treatable health issues, rather than moral failings, allows for SCFs to be  
discussed and implemented as health interventions to promote better health outcomes. 
Greater alignment with this way of problematizing drug use and overdose may result in 
an easier progression toward SCF implementation and less opposition upon the opening 
of a site.  
 
C5. Keep in Mind: Contextualizing Kingdon’s Theory in New Haven’s 
Reality 
 
 The final parent code utilized in this study was the code, “keep in mind,” reserved 
for topics and issues brought up by key informants that should be kept in mind when 
thinking about the implementation of supervised consumption in New Haven, but may 
not have seamlessly fit into other thematic codes. These codes serve to provide 
additional information about current factors at play in New Haven that provide nuance 
to how those looking to implement a SCF in New Haven should proceed through the 
potential policy window opening in the city. As with “facilitators” and “barriers,” “keep 
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in mind” was broken down into subcodes for greater clarity. These subcodes are labeled 
as center voices of PWLE/PWUDs, differing substance use, racial equity, and “what 
else,” understood as what else can be offered by a SCF in New Haven on top of 
supervised consumption services. In thinking about SCF implementation in New Haven, 
the response from key informants contained within these codes are important to 
remember, especially given that they are often left out of work that claims to be harm 
reduction, but fails to center harm reduction principles and the needs of PWUDs.109 
 
Center Voices of PWLE/PWUD  
 
 Key informants indicated that it is absolutely vital for any action or discussions 
around the implementation of SCFs to center the voices of people with lived experience 
(PWLE) and PWUDs. This goes hand in hand with the need for organizing or 
unionization of PWUDs in New Haven, but is distinct in that it requires action on the 
part of those with power, who are not PWUDs, to relinquish control and provide space 
for PWLE/PWUDs to lead in these discussions.  
“So, to go back to the community piece, just resurface when these discussions are 
happening, it's predominantly white people from Yale. And that needs to be 
figured out here, because I don't know how you intervene in New Haven without 
the community engaged and that can't happen if that's what the folks involved in 
this look like and, frankly, how their positioned…and you know that seems to be 
this community overall for how things get done and how intervention happens, 
but it really can't be. And people need to commit to and actually pony up the 
resources to create a space to center other leadership. And figure out what that 
can be and that's not going to be an overnight thing, but that has to happen 
overall in intervention around anything in social justice and health equity here 
and I would love to see that happen.”96 
 
Providing space for leadership by PWLE/PWUD may not happen overnight, but many 
key informants see the need for it as soon as possible.  
“There needs to be some cultural humility throughout the system, and I think 
that needs to happen immediately, and I think that it should lead to folks having 
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a seat at the table, and at the head of the table, but also because that will lead to 
better care for everybody.”88 
 
Centering the voices of PWLE/PWUD and allowing them to lead is not passive. It is 
something that takes deliberate action on the part of people with power and may be 
pivotal for New Haven’s ability to implement new harm reduction strategies, such as 
SCFs. 
Differing Substance Use 
 
 Another critical aspect of supervised consumption that key informants noted was 
the need for planning and implementation to be inclusive of differing substance use. 
This is seen in the deliberate reference to these facilities by a name that is inclusive, like 
“supervised consumption facilities” or “overdose prevention programs” rather than 
something more exclusive, like “supervised injection site.” Key informants noted the 
need for programming to include PWUDs who use substances other than and in 
addition to opioids and methods of consumption other than or in addition to injection.  
“But that that is to say that functionally not all people shoot and so therefore like 
if you're going to have a space for folks to hang out who snort or take pills or 
smoke, you need to you need to consider everybody, but also that a diversity of 
tactics really is what needs to be employed.”88 
 
The need for a diverse approach to a SCF that accommodates a variety of consumption 
methods and drug types is crucial, given the prevalence of intentional polysubstance use 
and the tainting of the drug supply, as noted, 
“So, this comes up, and I think this is everywhere, but not just opioids. Stimulant 
involved deaths are spiking. Everyone uses many things. And we don't know 
what's in any of those things, so any interventional approach needs to 
accommodate multiple types of drugs, multiple routes of administration from 
injecting to smoking to snorting to anything else.”96 
 
The inclusion of differences in substances used and their routes of administration in the 
planning and implementation of a SCF in New Haven would be critically important to 
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its ability to alleviate some of the burden that the overdose crisis puts on PWUDs. 
Finally, operating a SCF that is accepting and inclusive of differing substance use 
adheres to the core principles of harm reduction.109 
 
Racial Equity  
 
Another highly important component of SCF implementation and harm 
reduction in New Haven voiced by key informants was the need to proceed in a way that 
prioritizes racial equity. Drug use and harm reduction are, “deeply racialized”100 and in 
order to implement truly harm reductionist interventions, any progress made towards 
SCFs in New Haven will need to reckon with the racism of the War on Drugs and of the 
city itself.  
“I think unpacking NIMByism, unpacking racial politics. I think people need to 
reckon with crack/cocaine and the legacy of crack/cocaine and the 
destructiveness that in had in black communities and the way black communities 
have been harmed by policing, systemic poverty, disenfranchisement, loss of jobs, 
mass incarceration, and haven’t really felt safe.”91 
 
“Of course, this is all embedded in oppression and racism. And that's, the main 
thing, so I also think if we're if we're looking at our the racism that is 
institutionalized in our nonprofits, in our state government, and the United 
States…if we start dismantling those structures, we open up the possibility to be 
able to look at drug use in a different way.”99 
 
This racism is deeply rooted in all parts and parties that may be involved in 
implementation of a SCF in New Haven. It is vitally important that this work focus on 






What else?  
Finally, key informants noted that a SCF in New Haven, while it could be 
something as simple as a place where people are supervised during and after their drug 
use, could and should provide much more than that.  
“All supervised consumption does is give space to the primary overdose 
prevention recommendation that we give to folks who use drugs, which is don't 
use alone and have Naloxone with you. We really need to demystify this in the 
sense that it really actually could be that simple. It doesn't need to though. It 
could have a lot of other services mapped onto it because, frankly, people need a 
lot of supports. Often, probably not the ones you're thinking of you know, access 
to housing, assistance addressing entanglements with the with carceral systems, 
different things like that.”96 
 
We know that contact with additional services within a SCF lends itself to the 
improvement of health, well-being, and social functioning of people who access the 
sites.45 The inclusion of other services beyond supervised consumption within a SCF 
should be kept in mind when thinking about implementation of a facility in New Haven.  
 
D. Discussion and Strategic Planning  
Close reading of the statements of the key informants provided essential insights 
into the current landscape of facilitators, barriers, and other key factors at play when 
thinking about the implementation of a SCF in New Haven, CT. These insights provide 
an understanding of how New Haven is currently positioned with regard to the 
expansion of harm reduction services in the city and potential paths forward. Most 
importantly, they suggest that New Haven is headed towards a potential policy window 
in which the successful implementation of a SCF in the city may be feasible.  
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D1. Applying Kingdon’s Theory of ‘Alignment’ to New Haven 
 As previously introduced, John Kingdon’s Multiple Stream Theory indicates that 
a window for policy change opens upon the alignment of policy options, political 
circumstances, and problematization of a specific issue.5 The key informant interviews 
gave clear indication of how New Haven is currently situated within this framework. 
Responses from key informants indicated that supervised consumption is on the table as 
a policy option in New Haven. At various levels within the city of New Haven – the task 
forces, Community Services Administration, and the mayor – there are people in 
positions of power who have set forth supervised consumption as an option. This will 
need to be sustained in order to make the possibility of a SCF in New Haven become a 
reality. 
Key informants also elucidated that current political circumstances within the 
city may be aligned with this policy option and conducive to policy change around 
supervised consumption. Again, with a mayor and Community Services Administrator 
on board with SCF implementation, as well as reinforcement from the broader political 
circumstances currently shifting the United States, the political climate in New Haven 
seems very much open to supervised consumption. Hayle notes that the move towards 
supervised consumption in Canada was made partially possible by the election of less 
conservative politicians,95 a recent shift we have seen in New Haven, with the election of 
Justin Elicker as Mayor, in Connecticut with an empowered progressive wing in the 
state legislature,  and nationally, with the election of Joe Biden as President. Although 
there is lingering concern with regard to Connecticut being more purple than it is 
blue,107 the Connecticut State Legislature has started to show this shift toward more 
progressive policies, including efforts to legalize cannabis with provisions to increase 
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equity and account for past racial injustice in drug law enforcement,110 efforts to define 
harm reduction outreach staff as essential community health workers, and the need to 
spend the recent influx in opioid settlement111 and American Rescue Plan112 moneys on 
evidence-based practices. While the Biden administration has been relatively quiet 
regarding moves on supervised consumption specifically, the American Rescue Plan 
does designate $30 million to be used to, “support community-based overdose 
prevention programs, syringe service programs, and other harm reduction services.”112 
The language of “overdose prevention programs” may be of particularly use to those 
looking to implement SCFs in New Haven and is of critical note when held in 
conjunction with responses from key informants indicating that “overdose prevention” 
is the advised terminology when talking about SCF implementation. Additionally, 
coming to an understanding of what position the Biden administration will take vis a vis  
§ 844 and § 856 will be critical in taking steps to move forward on supervised 
consumption. 
It is in the final of Kingdon’s three streams, problematization, where my analysis 
of key informant responses indicates that New Haven is falling short. Although New 
Haven declared overdose a public health emergency in 2016,113 many in New Haven still 
view overdose, and substance use in general, through a lens shrouded by stigma, 
moralization, and criminalization that is misaligned with harm reduction’s 
understanding of substance use. Again, although there are people in positions of power 
in New Haven who are aligned with SCF implementation, alignment within the 
community will also be crucial to successful and sustainable policy change and 
implementation of a SCF in the city. Hayle notes, in comparing SCF implementation in 
Canada to the failure for implementation in England and Wales, that Canada was able to 
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implement SCFs because the potential to improve the health of PWUDs overshadowed 
the concerns about crime.95 If New Haven is going to fully open the policy window for 
supervised consumption services, there is work to be done to shift the point of concern 
and center the health and well-being of PWUDs.  
 
D2. Working Towards Aligned Problematization 
 Given the current alignment of supervised consumption as a policy option and 
the political circumstances in New Haven, there may be a need to act quickly with 
regard to SCF implementation in the city. However, this may also be the opportunity to 
employ the crucial relationship and trust building noted by the key informants. If those 
in New Haven who are working towards supervised consumption want to give it the best 
chance at passage and sustainability, open discussions, listening sessions, and 
relationship building with members of the community will be important. While this 
relationship building is crucial in and of itself, this process should work also towards 
creating aligned problematization of the overdose crisis and support, or at least 
permissiveness, of supervised consumption. These discussions would need to take place 
with people across the many communities of New Haven, across neighborhoods, 
demographics, among and between PWUDs and people who don’t, and should be led by 
people who are of the community, rather than someone who may be interpreted as an 
outsider. Work like this takes time, but in order to ensure the implementation of 
progressive action, it is critically important and must begin as soon as possible. It would 
be remarkably difficult to implement an overdose prevention and harm reduction 
intervention in the community if they do not problematize the morbidity and mortality 
of the overdose crisis as what they are – avoidable public health emergencies.  
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D3. Additional Strategic Planning 
 In addition to aligning problematization of substance use and the overdose crisis 
with the current policy options and political circumstances in New Haven, there are 
additional strategic steps that are likely to create movement towards the 
implementation of a SCF in the city. Beletsky et al. outline the critical steps that should 
be considered when attempting the implementation of a SCF, with two steps that are 
attainable for New Haven in an immediate sense; a decisive choice to pursue supervised 
consumption and planning for implementation.27 If applied to a New Haven context, 
these could work in support of the SCF implementation in the city.  
 
(1) There needs to be a decision by a local or state authority to pursue 
SCFs as an intervention.  
Although it appears that no official decisions of this type have been made 
for the City of New Haven or the State of Connecticut, the work of the mayor, 
Community Services Administration, and New Haven Taskforces appears to be 
working towards a way to decisively start this work. Once a choice like this is 
made public, it will be crucial that those involved have done their homework to 
prepare for not only implementation, but backlash as well. 
 
(2) The Planning Phase  
The multiple aspects of the planning phase in New Haven can and should be done 
simultaneously. The first part of planning, as articulated by Beletsky et al.,27 is the 
collection of evidence, which when applied to New Haven, would be a collection of 
evidence in support of supervised consumption facilities as well as evidence of the need 
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for such services in the city. As emphasized by key informants, the evidence of need 
cannot and should not be seen only through the lens of those within the academy of Yale 
or the city municipal buildings. This process must center the voices, experiences, and 
expertise of PWUDs in New Haven at every step. Here is where the New Haven 
Taskforces, made up of service providers, Yale academics, and city representatives can 
act as a facilitator and begin to give PWUDs a seat at the head of the table. Let their 
experiences of using substances, accessing harm reduction, and existing in New Haven 
serve as evidence and credible knowledge in addition to the countless studies that have 
already proved the efficacy of SCFs as an intervention. This process would also serve to 
re-structure the narratives of problematization by having PWUDs work in tandem with 
others to define the problem. Tangibly, this operationalizes as inviting PWUDs to be 
meaningfully involved in the planning of a SCF in New Haven, every step of the way, 
from discussions with City government, to decisions regarding who will operate the 
facility, to what exactly they want offered and so much more.  
The planning phase is also the time for garnering stakeholder support for 
supervised consumption in New Haven. This process should happen alongside the work 
to align the problematization of the overdose crisis. If not done carefully and 
deliberately, poorly managed relationship building could drive the process of alignment 
off the rails. Conversations, trust, and relationship building with stakeholders will need 
to include people from across the New Haven landscape, as articulated by one key 
informant, inclusive of community leaders, government leaders, treatment providers, 
EMS, and Yale New Haven Hospital.98 Building these relationships can hopefully garner 
buy-in from these groups, either as active support, silence, or non-interference. 
Implementation could also be facilitated if those of particular influence in the city, such 
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as government leaders, service organizations, and Yale New Haven Hospital, were to 
show buy-in through funding and active de-stigmatization efforts. In addition to all of 
these players,  stakeholder buy-in (again through active support, silence, or non-
interference) from PWUDs, business owners, other members of the Yale community, 
residents of New Haven who do not use drugs, and religious leaders will be essential. 
Hayle cites the buy-in from religious leaders as a contributing factor to the 
implementation of SCFs in Canada.114 The role and influence of religious leaders in New 
Haven is sizable97 and securing buy-in from religious leaders in the city could be 
strategically advantageous for those looking to implement SCFs.  
Finally, during the planning stage, Beletsky et al. recommend preparing for the 
legal ramifications at either the state or federal level, as well as analyzing the criminal 
codes and regulations governing the conduct of medical professionals.27 In at least one 
conversation (outside the key informant interviews) with a well informed and engaged 
legal and public health actor, I got the inference that the political climate at the local 
and state level suggests that neither state nor local officials would seek to take legal 
action against a SCF in New Haven.115 It will also be crucial to look into the regulations 
governing medical professionals in Connecticut, given their primary role in overdose 
prevention protocols at medicalized SCFs. If New Haven were to pursue a non-
medicalized peer model, allowing for employment of PWUDs at the SCF to do the job 
that physicians and nurses do in medicalized models, this may be less of concern and 
would also allow for continued meaningful involvement of PWUDs in not only 
accessing services, but doing the work they are already doing for each other in a way 
that compensates them for their skills. However, medicalized models are more widely 
accepted by the general population88 and therefore may be easier to implement in New 
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Haven. This would be an important opportunity for the input of PWUDs, in order to 
determine how they would want a facility to operate, listening to their input, and 
operationalizing it when implementing a site.  
An additional consideration, when preparing for the legal ramifications 
associated with the opening of a SCF in New Haven, would be the current Good 
Samaritan Law in Connecticut. Presently, this law provides immunity from civil or 
criminal liability for health care professionals who prescribe, dispense, and/or 
administer opioid antagonists (e.g. Naloxone), as well as anyone else who administers 
an opioid antagonist, “if acting with reasonable care” when they believe that someone is 
experiencing an opioid overdose.116 While the Good Samaritan Law currently reads as 
fairly comprehensive to protect those acting in good faith to reverse an overdose from 
these labilities,116 this law should be amended to ensure that individuals who operate, 
oversee, and provide care at SCFs, including physicians, nurses, and additional staff, 
are protected. The process of amending this law should take into account input from 
those working towards and in favor of SCF implementation, particularly PWUDS, 
healthcare professionals, and harm reduction organizations, in order to ensure that the 
law appropriately covers those supervising all sanctioned SCF activities. While working 
within or reforming federal law is often the first thought when preparing for the legal 
ramifications of SCF implementation, state level policies that influence the care of 
PWUDs, like the Good Samaritan Law, need to be considered as well.  
 
 Beyond the scope of Beletsky et al.’s scaffolding is the need to settle the issue of 
location that was identified by key informants. The process of choosing a location, or 
locations, for one or multiple SCFs in New Haven may very well be an arduous and 
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contentious process. While the talks around location(s) could and should certainly be 
brought up during the process of relationship building with stakeholders, it will also 
require more in-depth discussions and negotiations with the city, the Alders, business 
owners, and the residents of the neighborhoods in which a SCF could feasibly be 
located. While a brick and mortar building is often conceptualized as what a SCF might 
look like, it may also be beneficial for those looking to implement SCFs to look into 
mobile options, such as the overdose prevention van operated in Scotland.117 A mobile 
site or multiple mobile sites may allow for services to be accessible to more PWUDs in 
New Haven, given the way in which they are dispersed across the city, as noted by key 
informants.96 Additionally, something like a mobile site may actually be better protected 
from legal action by the federal government under the Controlled Substances Act as 
articulated by Judge Roth in the dissenting opinion in the United States vs. Safehouse 
3rd circuit decision. Judge Roth states: 
 “At oral argument, the government conceded that Safehouse could provide the 
exact same services it plans to provide in the Consumption Room if it did not do 
so indoors— if, for instance, it provided a Consumption Room inside a mobile 
van. Yet, according to the Majority’s interpretation of section 856(a)(2), 
Safehouse would be committing a federal crime, punishable by twenty years’ 
imprisonment, if the Consumption Room services were provided inside a 
building, rather than in a mobile van, parked in front.”93 
 
While the 3rd Circuit decision only sets precedent for the geographic areas within 
the 3rd Circuit (Pennsylvania, New Jersey, Delaware, and the Virgin Islands) and does 
not mean that SCFs have been ruled unlawful in the 2nd Circuit, which contains 
Connecticut, the ramifications are still highly salient. If mobile supervised consumption 
is a potential loophole against legal action, it may be wise for harm reductionists in New 
Haven looking towards SCF implementation to consider this option. Most importantly, 
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the model and location of a site will need to be informed by PWUDs and ultimately 
located or implemented in such a way that it is most accessible to them.118 
In addition to location, there are outstanding variables related to the 
implementation of SCFs in New Haven that will need to be accounted for, including the 
awaited action on the part of the state to allocate funds from the American Rescue Plan 
and the matter of who exactly would be charged with opening and operating a SCF in 
the city. To the first point, at time of writing, the funds from the American Rescue Plan 
(ARP) dedicated to community-based overdose prevention services, syringe access 
services, and other harm reduction services have yet to be rolled out in Connecticut. 
Along with the $30 billion for these services, the ARP allocates $1.5 billion dollars in 
state block grants for substance use disorder (SUD) programs, of which Connecticut is 
set to receive $18.2 million.112 In March 2021, a task force of Connecticut harm 
reduction organizations, service providers, physicians, advocates, and Yale faculty 
published a letter to Governor Lamont urging that the process of fund allocation include 
community-based organizations in every part of the process, as well as sustain and 
expand the state’s harm reduction services, invest in a harm reduction-centered  
workforce to address the opioid crisis and educate health professionals on how to 
identify, prevent and treat SUDs, invest in innovative ways to care for PWUDs, ensure 
that funds are not allocated to any measures or programs that perpetuate stigma and 
discrimination against PWUDs, and develop a transparent and public mechanism of 
accountability to ensure that funds are distributed across the state equitably and 
effectively.119 How these funds are allocated, both in process and to what entities, will 
highlight key factors influential for how SCF implementation in New Haven may 
proceed, including the Governor’s willingness to work with community-based 
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organizations, the prioritization of harm reduction, the dedication to evidence-based 
practices, and the support, or lack of interference, from the state regarding SCFs. 
Whether or not Governor Lamont will implement these recommendations in the process 
of distributing ARP funds is an unknown variable that should be accounted for and 
tracked by those looking to implement SCFs in New Haven.  
Tied to the issues of location and fund distribution is the unknown of what entity 
would be tasked with opening and operating a SCF in New Haven. This factor has 
remained unaddressed as the process for SCF implementation in the city has yet to 
formally progress. I do not aim to recommend a specific entity for the purpose of 
operating a SCF in the city, but urge that the process of selecting who will operate the 
SCF be a collaborative one, with input from services providers, city officials, physicians, 
Yale, and PWUDs in New Haven taken into account. The success of SCFs opening as 
research pilots indicates one potential way forward, but, again, does not directly 
implicate a specific entity for leading this pilot. The choice of who will operate the site 
should also be informed by the facilitators and barriers noted by key informants, namely 
the specific organizations in New Haven that work to facilitate SCF implementation, the 
taskforces convened in the city, and the role that Yale plays, both as a facilitator and a 
barrier. The question of who will operate a SCF in New Haven is currently left 
unanswered, but will need to be determined, and informed by community members 
from all across the city, if SCF implementation is to be viable. 
 The strategies and variables outlined here serve as important touchpoints 
towards the goal of supervised consumption implementation in New Haven, CT. While 
there are far more facets that contribute to the sustained operation and the 
acceptability, accessibility, availability, and quality of services provided by a SCF, they 
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are beyond the scope of this work. While the wheels are only first starting to turn on SCF 
implementation in New Haven, these strategies, as reinforced by key informants, global 
examples, and legal precedent will hopefully serve to support work towards supervised 
consumption in the city.  
 
E. Limitations of this Study  
While this study provided insight into the current landscape of barriers, 
facilitators, and current climate of opinions, understanding, and will for sanctioned SCF 
implementation in New Haven, there were certainly ways in which it was limited. This 
work serves as a starting point, not a finish line. Given the small sample size of key 
informant interviews and the type of key informants that contributed to this work, the 
finding and analysis are limited to the New Haven context and the perceptions and 
understandings of service providers, physicians, and Yale faculty. Future work would 
need to include input and analysis of interviews with local and state government 
officials, law enforcement, and first responders. Additionally, it will be important for 
future work towards either exploring SCFs in the city or actual implementation to 
consult with all of those parties, as well as residents of various New Haven communities, 
neighborhoods, and, crucially, people who use drugs. A final limitation of this study is 
that the qualitative analysis was conducted by a single coder, who was also the 
interviewer. While the interviews were coded multiple times, the use of a single person 
as interviewer and coder can introduce bias and does not allow for inter-rater reliability. 
Future work will want to consider the use of multiple codes in order to enhance inter-





The overdose crisis still presents a formidable public health emergency across the 
country. The ways in which the crisis has greatly impacted the City of New Haven, CT 
and the lives of PWUDs here are substantially injurious. Although many New Haven 
service providers, doctors, and harm reduction organizations have done tireless work to 
uplift and maintain the health and well-being the PWUDs in the city, the morbidities 
and mortalities associated with the overdose crisis continue to rise. It is time now, long 
overdue, to look towards other harm reductionist and evidence-based interventions. 
Supervised consumption facilities, whether they are housed in buildings, vans, tents, or 
any other model, present a highly efficacious and harm reductionist response to the 
ever-increasing overdose crisis in New Haven. The key informants interviewed for this 
work showed that New Haven may, at this moment or in the very near future, be in 
alignment with Kingdon’s Multiple Stream Theory, which posits that if 
problematization, policy options and political circumstances align, there is room for a 
significant change in innovation, here in initiating SCFs. By acknowledging the 
facilitators and barriers present in the city, identifying additional contributing factors to 
contextualize this effort in New Haven, and reinforcing the need for community focused 
relationship building, key informants indicated the potential ways forward for those 
looking to implement one or multiple SCFs in New Haven. The lessons imparted by the 
global and national examples, along with the responses from key informants, provide 
ways in which efforts for SCF implementation can work to shift and/or overcome the 
barriers currently at play and move the needle on harm reduction in New Haven. 
 It appears the city may be entering a key moment with an opportunity to create 
policy change. This is not only opportunistic, it is necessary. However, it is not 
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inevitable, as basic education and consensus building outside the specific knowledge 
circles of my key informants still needs to be done. Additionally, there needs to be 
deliberate actions on the part of those in power in New Haven to cede some of that 
power as well as space and time to PWUDs and to center their experience, needs, and 
critical expertise as harm reduction progresses in the city. This work serves to support 
current and future efforts of SCF implementation and looks to a more compassionate, 
harm reductionist, and destigmatizing practice for the health and well-being of people 
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X. Appendices  
 




I hope you are doing well. 
  
My name is Mariah Frank and I am a second year MPH student at the Yale School of 
Public Health (YSPH). As a second-year student, I am in the process of conducting my 
thesis research. The goal of my thesis is to explore the history of supervised 
consumption for drug use in the US and globally, the lessons learned from the 
legislative, administrative, and implementation processes of supervised consumption 
services (SCS), and use the thesis to develop and analyze the elements of potential 
strategic plans for implementation of supervised consumption services in New Haven, 
Connecticut. As part of my thesis, I am conducting qualitative, semi-structured 
interviews with key informants to learn about the climate in New Haven regarding harm 
reduction, sentiments towards supervised consumption, and the current barriers and 
facilitators to implementation of SCS in the city. 
  
This thesis is being conducted under the supervision of YSPH faculty. After undergoing 
an IRB review, this work was granted Not Human Subjects Research status. If you 
choose to participate, I will ask if you are willing to have our interview recorded so that I 
may transcribe your responses for qualitative analysis. If granted permission to record, 
the transcription will be de-identified through a removal of all identifying information 
and be given a number for organization. Additionally, the recordings will be destroyed 
upon transcription. If not granted permission to record, I will take notes during our 
interview that will also be de-identified and given a number for organization. While 
there are no formal plans to publish this thesis, parts of this paper may be repurposed as 
needed for public use in the hopes that it will inform future supervised consumption 
work. I will not include any statements attributable to you without specific permission 
for use. 
  
Based upon your previous work, I believe your insight would be crucially helpful to 
developing an understanding of what the future of SCS might look like in New Haven. 
As someone who is passionate about harm reduction and eager to learn about the 
possibilities for future harm reduction services in New Haven, I would very much 
appreciate if you would be willing to participate in an interview. 
  
If you are willing to participate, please respond as soon as convenient, and I will work to 
schedule your interview at times convenient to you.  All participation is of course 
voluntary and you can decide to withdraw at any time. 
  




B. Appendix B: Qualitative Interview Guide  
 
1. How did you come to be involved with harm reduction?  
a. What specific perspectives and experiences do you bring to this work? 
 
2. What seems to be the current climate around harm reduction in New Haven? In 
CT? 
a. Among service providers?  
b. Among clients/people who use drugs?  
c. Among New Haven residents?  
d. Among officials, including the Mayor's office, police, health and fire 
departments? 
 
3. Given the fact that the Federal government and its laws control access to 
‘controlled substances” who in CT or NHVN connects to, or advocates with the 
federal drug control implementers? 
 
4. How have different communities’ and others’ feelings around harm reduction 
played out in conversations around harm reduction services like syringe 
exchange, drop-in centers, and MAT in New Haven? How are these views and 
feelings made public? 
 
5. What are current facilitators for supervised consumption in New 
Haven/Connecticut?  
 
6. What are current structural, political, or institutional barriers to supervised 
consumption in New Haven?  
 
7. What might be next steps towards supervised consumption in New 
Haven/Connecticut?  
a. What role does the state play? 
b. Who are allies? Who are potential opposition voices? 
c. What are the oppositional voices saying? 
 
8. Is there anything else that needs to be considered when developing a strategic 
plan for a supervised consumption facility in New Haven?  
 
9. Would you be willing to share information about my thesis with other people in 
your network? 
a. If yes: I will email you and follow up after this interview to provide a short 
paragraph about the goals of this thesis so that you may forward it onto others 
who might be willing to speak with me. If they want to reach out, they can 
email me at mariah.frank@yale.edu.  
b. If no: Thank them for their time  
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C. Appendix C: Qualitative Codebook 
 
**Note: Bolded codes are Parent Codes. Codes indented and not-bolded are sub-codes 
hosted within the broader parent code.** 
Code Description Inclusion Exclusion 
Barriers Anything that may 




services in New 
Haven but does not 
qualify for any of 
the more specific 
barrier codes. 
 
This code includes 
any details 











Anything that is 
not indicated as a 
barrier by key 
informants is not 
included under this 
parent code.  
Barrier -- PWUD 
organizing 
How the current 
lack of PWUD 
organizing in New 
Haven may serve as 





how PWUDs are 
not currently 
organized in New 




would be different 
if there was a 
PWUD 
organization/ 
union, or other 
comments about a 
lack of PWUD 
organizing.  
Any comments 
unrelated to a lack 
of PWUD 




How the potential 
location selection 
process for a 
supervised 
consumption site 
may serve as a 








would make the 
process of siting a 
supervised 
Any comments 
unrelated to a 
choosing a location 
within New Haven 
or New Haven as a 










How a lack of 
funding/money 









New Haven being 
poor, Yale not 
paying it’s “fair 
share” to New 
Haven, questions 
around funding for 
a site and who 




unrelated to a lack 
of resources and/or 
funding as a barrier 
Barrier -- stigma How the continued 
presence of stigma 
around substance 
use and PWUDs 
may serve as a 








specifically in New 
Haven or the 
greater stigma 
around substance 
use and addiction 
in the U.S. 
Comments about 
“NIMBYism” may 
also be included 
here. 
Any comments 
unrelated to how 





Barrier -- Yale How Yale and Yale 
affiliated people 
and places may 
serve as a 





about Yale that 
specifically 
reference how it 




perceptions of Yale, 
Yale constantly 
doing research, 
Yale needing to 
give space for 
PWUDs to speak 
included here.  
Any comments 
unrelated to how 
Yale specifically 
serves as a barrier 
to implementation. 
Other comments 
about Yale may be 
housed under other 
codes. 
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Facilitators Anything that may 





services in New 
Haven, but does 
not qualify for any 
of the more specific 
facilitator codes. 
 
This code includes 
any details 











Anything that is 
not indicated as a 
facilitator by key 
informants is not 




The need for 
supervised 
consumption/more 




how a need for 
supervised 
consumption based 
on immediacy of 
the overdose crisis, 
increasing number 
of overdose deaths 
and morbidities, 




unrelated to how 
the need for 
supervised 
consumption as a 
harm reduction 





How the current 
task forces and 
working groups in 
New Haven around 
substance use and 
harm reduction 





the discussions had 
in task force 











unrelated to how 
the establishment 
and regular 
meetings of the 










New Haven focused 
on substance use 
and harm reduction 
may serve to help 
Comments about 
how organizations 
in New Haven who 
are already harm 
reduction minded 
and thinking about 
Any comments 











as facilitators to 
implementation. 





How the current 
grant from Vital 
Strategies and the 
new position 
created by the grant 
in New Haven may 





how the Vital 
Strategies Grant, 
the coordinator 
position, or related 







unrelated to how 
the grant awarded 
to the city by Vital 







How Yale serves as 
a facilitator for 
progress on harm 
reduction in New 
Haven  
Only comments 
about Yale that 
specifically 
reference how it 







power of Yale’s 





unrelated to how 
Yale specifically 




about Yale may be 
housed under other 
codes. 
Next Steps Important next 







what needs to start 
now in order to 
move forward. 
What very tangibly 
needs to start 
happening in order 
to for supervised 
consumption to 
potential become a 
reality in New 
Haven. 
Any comments 
unrelated to the 
next steps that 
need to be taken in 






Policy options Indicates options 
that are on the 
table for current 
policy change to 
address drug 
overdoses or how 
supervised 
consumption is 





being discussed as 
an option in New 
Haven or how the 
current discussions 
in other state 
provide space to 
supervised 
consumption to be 
considered an 
option in New 
Haven.  
Any comments 
unrelated to how 
supervised 
consumption is 















New Haven and in 
the country and 




is onside? Who is 
not? What does 












Problematization How overdose and 
drug use has been 




about the overdose 
crisis, how people 
conceptualize the 
problems 
associated with it  
Any comments 
unrelated to how 
people 
problematize the 
overdose crisis and 
the comorbidities 
of substance use 
Keep in Mind Other important 
notes that should 




This code includes 
any details 
provided by key 
informants that 
researcher deemed 
to be highly 
Any comments not 
perceived or 
determined by the 
researcher as 
important to be 






important to keep 
in mind since many 
of these aspects are 
often 
problematically 





important to flag 





While this is a 
subjective code, 
most other content 
from key informant 
interviews were 
either coded 
elsewhere or not 
relevant to the 
study purpose. 
Center Voices of 
PWLE/PWUD 
The need to and 
way in which 
people with lived 
experience and 
people who use 
drugs should be 




people with lived 
experience and 
people who use 
drugs needs to be 
brought to the table 






unrelated to how 
PWLE and/or 









The importance of 
centering and 
including different 
types of substance 
use and different 




Comments on how 
supervised sites 
cannot just focus 
on injection or on 
opioids. Attention 
needs to be paid to 
other modes of 
consumption and 








to include differing 
substance use.  
Legacy of Yale How Yale's 
previous role in 
harm reduction in 
New Haven plays 
out currently and 





the role Yale has 
played historically 
in New Haven, on 
harm reduction 
action and 
research, etc.  
Descriptions of 
Yale and Yale’s 
influence unrelated 
to its role as a 
facilitator or 
barrier. Those 







How racial equity 
needs to be 







how people of color 
are not being 
considered or 
brought to the table 
but need to be in 






segregation of New 
Haven and racial 




unrelated to how 
PWLE and/or 







What else? Identify the need 
for supervised 
consumption but 
also note that there 
is so much else that 
is needed.  
 
Comments 
regarding the need 
for supervised 
consumption that 
is couched within 
other services and 
connects those who 
access the site to 
other services they 
need in the city.  
Any comments 
unrelated to a 
supervised 
consumption 
facility would need 
to be housed within 
or encompass other 
services to meet the 
needs of PWUDs in 
New Haven. 
 
 
